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ABSTRACT
Zoonotic diseases are infectious diseases that can be transmitted from or
through animals to humans, and arthropods often act as vectors for transmission.
Emerging infectious diseases have been increasing both in prevalence and
geographic range at alarming rates the last 30 years, and the majority of these
diseases are zoonotic in nature.

Many zoonotic diseases are considered

notifiable by the Centers for Disease Control and Prevention (CDC). However,
though state regulations or contractual obligations may require the reporting of
certain diseases, significant underreporting is known to exist. Because of the
rich volume of information captured in health insurance plan databases,
administrative medical claims data could supplement the current reporting
systems and allow for more comprehensive spatio-temporal analyses of zoonotic
infections.
The purpose of this dissertation is to introduce the use of electronic
administrative medical claims data as a potential new source that could be
leveraged in ecological field studies in the surveillance of arthropod-borne
zoonotic diseases.

If using medical claims data to study zoonoses is a viable

approach, it could be used to improve both the temporal and spatial scale of
study through the use of long-term longitudinal data covering large geographic
expansions and more geographically refined ZIP code scales.

Additionally,

claims data could supplement the current reporting of notifiable diseases to the
CDC. This effort may help bridge the disease incidence gap created by health
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care providers’ underreporting and thus allow for more effective tracking and
monitoring of infectious zoonotic diseases across time and space.
I specifically examined 5 tick-borne (Lyme disease [LD], babesiosis,
ehrlichiosis, Rocky Mountain spotted fever [RMSF], and tularemia) and 2
mosquito-borne (West Nile virus, La Crosse viral encephalitis) diseases known to
occur in the southeastern US. I first compared disease incidence rates from
cases reported to the Tennessee Department of Health (TDH) state registry
system with medically diagnosed cases captured in a southeastern managed
care organization (MCO) claims data warehouse.

I determined that LD and

RMSF are significantly underreported in Tennessee.

Three (3) cases of

babesiosis were discovered in the claims data, a significant finding as this
disease has never been reported in Tennessee. Next, I used a cluster scan
statistic to statistically validate when (temporal) and where (spatial) these data
sources differ. Findings highlight how the data sources do not overlap in their
significant cluster results, supporting the need to integrate administrative and
state registry data sources in order to provide a more comprehensive set of case
information. Once the usefulness of administrative data was demonstrated, I
focused on how these data could improve spatio-temporal macro-scale analyses
by examining information at the ZIP code level as opposed to traditional county
level assessments.

I expanded on the current literature related to spatially

explicit modeling by employing more advanced data mining modeling techniques.
Four separate modeling techniques were compared (stepwise logistic regression,
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classification and regression tree, gradient boosted tree, and neural network) to
describe the occurrence of tick-borne diseases as they relate to sociodemographic, geographic, and habitat characteristics. Covariates most useful in
explaining LD and RMSF were similar and included co-occurrences of RMSF and
LD,

respectively,

amount

of

forested

and

non-forested

wetlands,

pasture/grasslands, and urbanized/developed lands, population counts, and
median income levels. Finally, I conclude with a ZIP code level spatio-temporal
modeling exercise to determine areas and time periods in Tennessee where
significant clusters of the studied diseases occurred. ZIP code level clusters
were compared to the previously defined county-level clusters to discuss the
importance of spatial scale. The findings suggest that focused disease/vector
prevention efforts in non-endemic areas are warranted.
Very little work exists using administrative claims data in the study of
zoonotic diseases. This body of work thus adds to an area void of much
knowledge. Administrative medical claims data are relatively easy to access
given the appropriate permissions, have relatively no cost once access is granted,
and provides the researcher with a volume rich dataset from which to study. This
data source should be properly considered in the wildlife and biological sciences
fields of research.
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CHAPTER 1
IMPORTANCE OF STUDYING ZOONOTIC DISEASES

INTRODUCTION
Zoonotic diseases, also termed zoonoses, are infectious diseases that can
be transmitted from or through animals to humans, and arthropods often act as
vectors for transmission. Emerging infectious diseases have been increasing
both in prevalence and geographic range at alarming rates the last 30 years, and
the majority of these diseases are zoonotic in nature (Jones et al. 2008).
Zoonotic diseases are of significant concern to public health and account for
approximately 75% of recently emerging infectious diseases, and approximately
60% of all human pathogens originate from animals (CDC NCEZID 2010).
Zoonoses can be in the form of viral (e.g., West Nile virus), bacterial (e.g., Lyme
disease), fungal (e.g., Histoplasmosis), protozoan (e.g., babesiosis) or parasitic
(e.g., Filariasis) infections. These zoonotic diseases can pose a serious public
health threat as some diseases such as rabies, though rare, can be fatal, while
others (e.g., ringworm) are minor health concerns. Even when incidence rates
are relatively low, large-scale public health scares can emerge (e.g., West Nile
and H1N1 viruses).
Arthropods (e.g., mosquitoes, ticks, mites, spiders) make up over 80
percent of all animal species but only a very small percentage of the over 1
million described species are potentially dangerous to humans (Goddard 2008).
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However, arthropods can serve as vectors for the transmission of zoonotic
diseases from the infected animal (reservoir) to a susceptible human host.
Diseases transmitted by arthropods are thus termed arthropod-borne diseases
(Eisen and Eisen 2007). The ability for vectors to successfully transmit disease
from reservoir to host depends on many factors including vector physiology,
morphology, reproductive capacity, and genetics. Additionally, the occurrence,
extent, and suitability of arthropod habitats depend on multiple factors such as
temperature, topography, moisture, rainfall, soil pH, weather, and geographical
location.

Human induced factors may also contribute to the rise in disease

prevalence because of climate change, public health policy, lack of prevention
and control, and increasing urbanization (Goddard 2008).
Many zoonotic diseases are considered notifiable by the Centers for
Disease Control and Prevention (CDC).

This means that when a case is

diagnosed or suspected, the diagnosing clinician (i.e., health care provider)
should report this information to their local or state health department. In addition
to diagnosing and treating individual patients, health care providers play an
important role in protecting the public health through the identification and
reporting of infectious diseases.

Health care providers are typically the first

health officials to encounter cases of infectious zoonotic diseases, and therefore
play an important role in disease surveillance activities (GAO 2004).

Health

insurance plans, sometimes referred to as managed care organizations (MCO),
contract with providers to deliver health care to their members. Therefore, there
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is both a direct (self-reporting) and indirect (provider-reporting) responsibility of
health plans in the reporting of infectious diseases. Indirectly within their legally
binding contract with providers, health plans could require providers to report
100% of diagnosed cases. However, though state regulations or contractual
obligations may require the reporting of certain diseases, underreporting still
exists as not all diagnosed or suspected cases are reported by health care
providers (Marier 1977; Meek et al. 1996; Young 1998; Koo and Caldwell 1999),
and can vary by physician specialty (Campos-Outcalt et al. 1991).
Medical claims data are recorded within the healthcare system every time
a patient visits their doctor or hospital for a medical service, fills a prescription
medicine, or seeks consultation from a clinician. Of particular interest is the
amount of available data from MCOs, as well as the temporal and spatial
granularity of captured data elements from each medical encounter. Medical
claims data contain, among other things, the patient’s ZIP code at the time of
service, date of medical service, and medical diagnosis codes which describe the
reason why the patient is seeking medical care. The geographic element of a
patient’s residence location combined with the date of diagnosis provides both a
spatial and temporal “stamp” of what the patient was exposed to, and potentially
when and where the exposure may have occurred.
Medical claims data may aid in the study and tracking zoonoses. If using
medical claims data is a viable approach, it could be used to improve both the
temporal and spatial scale of study through the use of long-term longitudinal data
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covering a large geographic expansion and at a more geographically refined
scale.

Additionally, claims data could supplement the current reporting of

notifiable diseases to the CDC.

This effort may help bridge the disease

incidence gap created by health care providers’ underreporting and thus allow for
more effective tracking and monitoring of infectious zoonotic diseases across
time and space.

BACKGROUND
Southeastern Arthropod-borne Diseases
Arthropod-borne diseases are infectious diseases in which arthropods are
considered a transmitting vector or intermediate host. These diseases can be
separated into categories based upon vector phylogeny. The most prevalent
vectors in the southeastern US and the primary focus of this study are ticks and
mosquitoes, and thus this study proposes to categorize diseases as tick-borne
and mosquito-borne, respectively.

Specifically, we examine five tick-borne

(Lyme disease, babesiosis, ehrlichiosis, Rocky Mountain spotted fever, and
tularemia) and 2 mosquito-borne (West Nile virus and La Crosse viral
encephalitis) diseases known to occur in the southeastern US (Table 1-1). For
the purposes of this study, the southeast was considered South Carolina, North
Carolina, Georgia, Tennessee, Florida, Alabama, Mississippi, Louisiana, and
Arkansas (Figure 1-1).
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Tick-borne Diseases (Table 1-1)
Borreliosis - Lyme disease (ICD-9 Diagnosis Code: 088.81 *)
Lyme disease is the most frequently reported vector-borne disease in the
US (Varela et al. 2004) with 29,780 cases reported nationwide in 2009, with 32
occurring in Tennessee (CDC MMWR 2010). Lyme disease is caused by the
bacterium Borrelia burgdorferi, which is transmitted to humans via the
Blacklegged or deer tick (Ixodes scapularis), the same tick responsible for
transmitting babesiosis and certain forms of ehrlichiosis. Symptoms include a
characteristic “bulls-eye rash” within 2 weeks after exposure, fever, headache,
and fatigue. If left untreated, infection can spread to joints, the heart, and the
nervous system. Most cases of Lyme disease can be treated successfully with a
few weeks of antibiotics. The majority of diagnosed cases occur in the New
England area, upper Mid-West, southeastern US, and Pacific Coast states.

Babesiosis (ICD-9 Diagnosis Code: 088.82)
Babesiosis is an uncommon tick-borne malaria-like illness caused by the
Babesia microti organism, which usually infects white-footed mice and other
small mammals.

This organism is then transferred to humans by Ixodes

scapularis (CDC NCEZID 2010).

Most cases of babesia infection are

asymptomatic or include mild fevers and anemia while more severe cases carry
symptoms similar to malaria and can be life-threatening. Reported cases are on

*

See below for a detailed description of the ICD-9 medical coding system
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the rise, perhaps because of expanded medical awareness (Hunfeld et al. 2008).
In North America, the disease is most commonly found in the Northeast and
upper Midwest, particularly in parts of New England, New York, New Jersey,
Wisconsin, and Minnesota. According to the Tennessee Department of Health
Communicable Disease Interactive Data Site, there have been no reported cases
within Tennessee for the 1995-2009 time period. However, a recent 2010 report
indicates what they believe to be the first zoonotic babesiosis case documented
in Tennessee (Mosites et al. 2010).

Rickettsiosis – Rocky Mountain spotted fever (ICD-9 Diagnosis Code: 082.0)
Rocky Mountain spotted fever is the most severe tick-borne rickettsial
illness in the US and is caused by the Rickettsia rickettsii bacterial organism.
Infections occur most commonly in the southeastern and south central US and
are typically transmitted from the bite of an infected American Dog tick
(Dermacentor variabilis). Symptoms include the development of a rash within 2
to 4 days after the onset of fever, and can be non-descript or mimic other
illnesses with headache, muscle pain, nausea, and lack of appetite. In 2009
there were 1,393 cases reported nationwide, with 184 occurring in Tennessee
(CDC MMWR 2010).
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Ehrlichiosis – human monocytic ehrlichiosis, Ehrlichia chaffeensis (ICD-9
Diagnosis Code: 082.41)
Ehrlichia chaffeensis can refer to both the disease name and the
responsible bacterial pathogen. Ehrlichiosis caused by E. chaffeensis is also
referred to as human monocytic ehrlichiosis (HME).

As with tularemia, HME is

associated with bites from the Lone Star tick (Amblyomma americanu) and is
characterized by acute onset of fever and headache, malaise, anemia, nausea,
vomiting, and/or a rash. This disease occurs most often in the Southeastern and
Midwestern US, and the number of diagnosed cases have risen steadily from
1999 – 2006 (CDC NCEZID 2010). In 2009 there were 122 cases reported
nationwide, with 16 occurring in Tennessee (CDC MMWR 2010).

Tularemia - (ICD-9 Diagnosis Code: 021)
Tularemia is a relatively uncommon but potentially fatal infectious disease
most common in the south central US, Pacific Northwest, and Massachusetts. It
is caused by the bacterium Francisella tularensis which is transmitted to humans
through the bite of 2 different ticks, the American dog tick and the Lone Star tick.
Tularemia can also be transmitted through the handling of infected animal
carcasses, consuming contaminated food or water, or breathing in the bacteria.
Because of the latter aerosol transmission capability, this disease is considered a
possible bioterrorism indicator and is classified as a category 1B disease, which
requires immediate telephonic notification followed by a written report within 1
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week of diagnosis (TDH CEDS 2010).

Symptoms occur within 5 days of

exposure and include a sudden fever onset, chills, headache, diarrhea, muscle
and joint pain, dry cough, difficulty breathing, and progressive weakness.

In

2009 there were 123 cases of tularemia reported nationwide, with only 2
occurring in Tennessee (CDC MMWR 2010).

Tick Species
Blacklegged tick, deer tick (Ixodes scapularis)
This tick is widely distributed in the northeastern and upper midwestern
US (Figure 1-2; Figure 1-3) and can transmit Borrelia burgdorferi (responsible for
Lyme disease) and Babesia microti (responsible for babesiosis). Larvae and
nymphs feed on small mammals and birds, while adults feed on larger mammals
and will bite humans on occasion. It is important to note that the pathogen that
causes Lyme disease is maintained by wild rodent and other small mammal
reservoirs, and is not transmitted everywhere that the blacklegged tick lives. In
some regions, particularly in the southern US, the tick has very different feeding
habits that make it an unlikely vector in the spread of human disease (CDC
NCEZID 2010).

Lone Star tick (Amblyomma americanum)
This tick is primarily found in the southeastern and eastern US (Figure
1-3) and is responsible for the transmission of organisms causing forms of
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borreliosis

(Southern Tick-Associated Rash Illness), ehrlichiosis (human

monocytic ehrlichiosis), and tularemia. White-tailed deer are a major host of Lone
Star ticks and appear to represent a natural reservoir for Ehrlichia chaffeensis.
Larvae and nymphs feed on birds and deer (CDC NCEZID 2010).

American Dog tick (Dermacentor variabilis)
This tick is the most commonly identified species responsible for
transmitting the Rickettsia rickettsii bacterial organism and causes Rocky
Mountain spotted fever in humans. This tick can also transmit tularemia. It is
widely distributed east of the Rocky Mountains and also occurs in limited areas
on the Pacific Coast (Figure 1-3). Larvae and nymphs feed on small rodents.
Dogs and medium-sized mammals are the preferred hosts of adult ticks,
although it feeds readily on other large mammals, including humans (CDC
NCEZID 2010).

Mosquito-borne Diseases
Arthropod-borne viruses are primarily transmitted during the summer and
fall in the US, with disease incidence peaking in late summer. Presently, there
are two more commonly described mosquito-borne viral diseases (La Crosse and
West Nile) occurring in the southeastern US.
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La Crosse viral encephalitis (ICD-9 Diagnosis Code: 062.5)
La Crosse viral encephalitis (LACV) is a relatively uncommon viral illness
transmitted to humans by the bite of an infected Aedes Triseriatus mosquito.
Most cases occur in the upper Midwestern, mid-Atlantic, and southeastern states.
Though most often asymptomatic, if symptoms do occur they include fever,
headache, nausea, vomiting, and general malaise. If the infection is more severe
(typically in children under 16), encephalitis can form and can include seizures,
coma, and paralysis. In rare cases, long-term disability or death can result. In
2009, there were 8 confirmed cases in Tennessee (USGS ArboNet 2009).

West Nile virus (ICD-9 Diagnosis Code: 066.4)
The West Nile virus (WNV) was first detected in the US in 1999 and
became notifiable in 2002. WNV is spread to humans through the bite of an
infected mosquito, typically thought to be the Culex pipiens mosquito, which
become infected after feeding on infected birds. Though the virus quickly spread
across the US from 1999 through 2001, neuroinvasive disease incidence
remained low until 2002 when large outbreaks in the Midwest and Great Plains
occurred.

Approximately 80 percent of people infected with WNV are

asymptomatic. Less than 1% of people infected will have severe life-threatening
symptoms, such as high fever, neck stiffness, stupor, disorientation, coma,
tremors, convulsions, muscle weakness, vision loss, numbness, and paralysis.
There were 329 reported cases of non-neuroinvasive West Nile virus in 2009, 4
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of which occurred in Tennessee. Additionally, there were 361 reported cases of
neuroinvasive West Nile virus in 2009, 4 of which occurred in Tennessee (CDC
MMWR 2010).

Mosquito Species
Eastern tree hole mosquito (Aedes triseriatus)
This mosquito species is found in wooded regions of eastern and central
North America, particularly in areas with temporary pools of stagnant water, such
as tree holes and abandoned tires. It favors pools which contain leaf debris and
other organic material to provide food for its larvae. Adults remain in areas near
larval habitats throughout their lifespan. Aedes triseriatus occurs from Florida,
north to Ontario and west to Texas (CDC NCEZID 2010).

Northern house mosquito (Culex pipiens)
This mosquito is usually the most common pest mosquito in urban and
suburban settings and serves as an indicator of polluted water in the immediate
vicinity. It is recognized as the primary vector of St. Louis encephalitis and West
Nile virus in the eastern US and is normally considered to be a bird feeder,
though some urban strains may prefer mammalian hosts (CDC NCEZID 2010).
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Notifiable Diseases
According to the TDH, notifiable diseases are:
“declared to be communicable and/or dangerous to the public and
are to be reported to the local health department by all hospitals,
physicians, laboratories, and other persons knowing of or
suspecting a case in accordance with the provision of the statutes
and regulations governing the control of communicable diseases in
Tennessee.”

Improving Macro-scale Analyses by Aggregating to the ZIP Code Level
The reporting and tracking of illness cases is essential to knowing who is
infected and where the problems are occurring. A major limitation in the study of
such diseases, however, is the ability to comprehensively track disease
incidence over space and time at a meaningful geographic scale.

Data

aggregations and disease incidence is most often presented at the county level
(Sugumaran et al. 2009). Unfortunately, county level assessments compared to
ZIP code level analyses may mask smaller isolated high risk areas as well as
obscure within county variability (Mostashari et al. 2003; Eisen et al. 2006). In
2007, the CDC called for a means to improve data collection methods to
determine probable pathogen exposure sites based specifically on patient activity
spatial patterns. This suggests geocoding the residential location (street address
or ZIP code) of the infected patient and conducting a radial search around that
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point to examine the underlying landscape. However, data describing possible
pathogen exposure sites (i.e., patient’s actual residential location information) are
limited (Glass et al. 1995; Eisen and Eisen 2007), and means to collect this
information can be very costly (e.g., patient surveys). Therefore, studies within
the wildlife and ecological sciences are often limited in predictive power due to
the inability to generate large sample sizes, either because of costs, data
availability or both (Bissonette 1999).

Health plans and their associated

administrative data may help improve this data deficiency.

Role of Health Plans and Providers in the Monitoring of Infectious Diseases
As previously mentioned, MCOs play a major role in the tracking of
infectious diseases.

Medical claims data are recorded within the healthcare

system every time a patient visits their doctor or hospital for a medical service,
fills a prescription medicine, or seeks consultation from a physician. Therefore,
all diagnosed zoonotic infections where patients are seeking monetary
reimbursement from their health plan would be documented in the plans’ claims
data warehouse.

If the services rendered are from an actual person (e.g.,

physician), a HCFA-1500 form is completed and submitted to the health plan
covering the patient.

If the services rendered are billed from a facility (e.g.,

hospital), a UB-92 form is completed.

These forms are very similar and capture,

among other things, patient information (name, date of birth, address, ZIP code),
date of service, services rendered, and diagnosis information (described below in
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detail in the ICD-9 coding system). The term “electronic” refers to data that is
stored electronically in a data warehouse. The term “administrative” refers to
data that is transferred from the claim form to the health plan’s data warehouse.
Administrative data does not typically include elements like lab results (e.g.,
blood pressure, white blood cell count).

International Classification of Diseases (ICD) Medical Coding System
The ICD coding system is used throughout the healthcare industry to
describe diseases, injuries, symptoms, complaints, and conditions encountered
when patients visit a health care provider. Under this coding system, similar
health conditions can be categorized together, and each condition/diagnosis is
assigned a unique code, up to six characters long in a hierarchical listing. The
ICD codes are revised periodically, and the majority of the US currently uses the
9th edition (ICD-9). For example, a patient diagnosed as having West Nile virus
could be given a 3-digit ICD-9 code of “066” indicating a diagnosis of an
“arthropod-borne viral disease.” More specifically, the patient would be given a 4digit ICD-9 code of “066.4,” which indicates “West Nile Fever.” And even further,
the health care provider could be more specific with the coding if certain
symptoms were present, or certain tests confirmed the presence of something.
For example, the ICD-9 hierarchy of diagnosis code “066” is:
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066 Other arthropod-borne viral diseases
066.4 West Nile Fever
066.40 West Nile fever, unspecified
066.41 West Nile fever with encephalitis
066.42 West Nile fever with other neurological manifestation
066.49 West Nile fever with other complications

Another important aspect of diagnosis coding on a claim form is that a
medical encounter can have more than one diagnosis code. The initial most
important diagnosis (as deemed by the health care provider) is the primary
diagnosis, and other diagnoses would be considered secondary, tertiary, and so
on.

For example, a physician could see a patient about their illness and

determine that West Nile fever is the primary diagnosis (066.4). The physician
may also code, on the same claim form, another secondary diagnosis for a
headache (784.0) and tertiary diagnosis for nausea (787.02).

Data in the

BlueCross BlueShield of Tennessee (BCBST) data warehouse capture up to 8
diagnosis codes.
Of particular interest is the amount of available data from health plans, as
well as the temporal and spatial granularity of captured data elements from each
medical encounter.

Medical claims data contain, among other things, the

patient’s ZIP code at the time of service, date of medical service, and medical
diagnosis codes which describe the reason why the patient is seeking medical
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care. The geographic element of a patient’s residence location combined with
the date of diagnosis provides both a spatial and temporal “stamp” of what the
patient was exposed to, and potentially when and where the exposure may have
occurred.

Therefore, this administrative data source could supplement the

current reporting and tracking structure and provide a better estimate of the true
incidence rate.

OBJECTIVES
A major limitation in spatial epidemiology is the collection of relevant
longitudinal data at the appropriate geographic scale. Research often relies on
drawing conclusions from only limited sample sizes usually taken either at a
static point in time, or some periodic time interval convenient for sampling, which
is further constrained by sampling cost. Additionally, diseases must be reported
to the CDC or health departments in order to be recorded in the database, and
clinicians or infected patients may not always manually report these.
This study proposes to introduce the use of electronic administrative
medical claims data as a potential new source that could be leveraged in
ecological field studies in the analyses and monitoring of arthropod-borne
zoonotic diseases.

If using medical claims data to study zoonoses is a viable

approach, it could be used to improve both the temporal and spatial scale of
study through the use of long-term longitudinal data covering a large geographic
expansion and at a more geographically refined ZIP code scale. Additionally,
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claims data could supplement the current reporting of notifiable diseases to the
CDC. This effort may help bridge the disease incidence gap created by health
care providers’ underreporting and thus allow for more effective tracking and
monitoring of infectious zoonotic diseases across time and space.

Specifically, the 4 main objectives of the study are:
1. To determine if certain notifiable diseases are underreported based on a
comparison of MCO administrative claims data and the TN State Health
Department (TDH)
2. To determine how MCO and TDH data compare/differ in the context of
spatio-temporal cluster analyses at the county level
3. To

determine

what

geographic,

habitat,

and

socio-economic

characteristics may be useful in explaining the occurrence of zoonotic
diseases
4. To determine where and when (if any) significant spatial and temporal
clusters of selected diseases occurred across the state of Tennessee for
the 2000-09 time period using MCO data at the ZIP code level

To my knowledge, this project is one of only a very small number of projects
that attempt to use administrative data from a MCO to study zoonotic diseases.
If successful, this could provide quantifiable evidence of more accurate estimates
of disease prevalence. Additionally, there is a multi-state initiative within the
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BlueCross BlueShield Association (BCBSA) to combine multiple BlueCross plans’
claims data into one centralized data warehouse. This combined data source will
contain information on approximately 100 million people across the entire US and
thus serve as a potentially powerful data source for mapping and monitoring of
zoonotic diseases.

DISSERTATION OVERVIEW
The dissertation is arranged in 5 chapters, where the first serves as a
basic introduction to the work, and the last 4 chapters are written as independent
papers. Because each project is undertaken individually with the explicit purpose
of publication, some information/verbiage contained within the chapters may
overlap.
Chapter 2 addresses the feasibility of using administrative medical claims
data in the analysis and tracking of infectious zoonotic diseases. The objective is
to determine if notifiable diseases are underreported. This is done by comparing
the TDH data with administrative claims data extracted from the BlueCross
BlueShield of Tennessee data warehouse, later defined as the MCO.

The

general hypothesis is there is no difference between the state reported incidence
rates for a selected disease and the MCO claims derived incidence rate.
Chapter 3 builds on Chapter 2 and compares zoonotic case information
derived from the TDH state registry system with MCO administrative medical
claims information to statistically validate when (temporal) and where (spatial)
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these data sources differ. The general research hypothesis is that no differences
in clusters exist between the two data sources.
Once MCO data is determined to be useful, Chapter 4 addresses the need
to study potential site characteristics at a finer scale (i.e., ZIP code) as opposed
to traditional county level analyses using administrative data. Specifically, the
objective is to determine what, if any, site level characteristics may be influential
in explaining disease occurrence.

The general research hypothesis is

geographical/habitat characteristics do not influence the presence of zoonotic
diseases.
Chapter 5 takes information learned from Chapters 2 – 4 and attempts to
address the feasibility of using MCO data in the tracking of zoonotic diseases at
the ZIP code level. Specifically, the objective is to determine where and when
significant spatial and temporal clusters of selected diseases occurred, and
compare these findings to county-level outcomes.

The general research

hypothesis is there are no significant spatial or temporal clusters of disease
incidence across Tennessee for the study period.
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Table 1-1: Arthropod-borne zoonotic diseases known to occur in the
southeastern US and selected for study
Disease
Borreliosis

Common
Name
Lyme
disease

Pathogen
Type
Bacterial

Babesiosis

Babesiosis

Protozoan

Babesia
microti

Tick

Blacklegged,
or deer tick

(Ixodes
scapularis)

Rickettsiosis

Rocky
Mountain
spotted
fever

Bacterial

Rickettsia
rickettsii

Tick

American
dog tick

(Dermacentor
variabilis)

Ehrlichiosis

Human
Monocytic
Ehrlichiosis

Bacterial

Ehrlichia
chaffeensis

Tick

Lone star
tick

(Amblyomma
americanu)

Tularemia

Tularemia

Bacterial

Francisella
tularensis

Tick

American
dog tick,
Lone star
tick

(Dermacentor
variabilis,
Amblyomma
americanum)

La Crosse
Encephalitis

La Crosse
viral
encephalitis

Viral

La Crosse
encephalitis
virus

Mosquito

Eastern tree
hole
mosquito

(Aedes
triseriatus)

West Nile
Fever
(Virus)

West Nile
virus

Viral

West Nile
Virus

Mosquito

Northern
house
mosquito

(Culex
pipiens)

Pathogen
Borrelia
burgdorferi
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Vector
Type
Tick

Primary Vector
Blacklegged, (Ixodes
or deer tick
scapularis)

Figure 1-1: Map indicating southeastern states according to this study
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Figure 1-2: Approximate distributions of the Blacklegged Tick (Ixodes scapularis),
the Lone Star tick (Amblyomma americanum) and the American Dog tick
(Dermacentor variabilis) (images source: CDC)
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Figure 1-3: Life stages and relative sizes of 3 tick species known to be primary
vectors for zoonotic diseases (image source: CDC)
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CHAPTER 2

USING ADMINISTRATIVE MEDICAL CLAIMS DATA TO ESTIMATE
UNDERREPORTING OF INFECTIOUS ZOONOTIC DISEASES

ABSTRACT
Notifiable diseases require regular, frequent, and timely reporting of
diagnosed cases to aid in prevention and control. However, manual reporting
can be burdensome, incomplete, and delayed.

Administrative claims data

captured from clinical encounters details the patient's reason for seeking care,
service date, and place of residence.

To determine if administrative data is

useful in the tracking and reporting of diagnosed zoonotic diseases, 5 tick-borne
(Lyme disease [LD], babesiosis, ehrlichiosis, Rocky Mountain spotted fever
[RMSF], tularemia) and 2 mosquito-borne (West Nile virus, La Crosse viral
encephalitis) diseases known to occur in the southeastern US were examined.
Disease incidence rates from cases reported to the Tennessee Department of
Health (TDH) and medically diagnosed cases captured in a southeastern
Managed Care Organization (MCO) claims data warehouse were compared
using a complete randomized block design within a general linear mixed model.
LD incidence was 7.7 times higher (P < 0.001) than what was actually reported to
the state, possibly indicating significant underreporting (~196 unreported cases
per year in TN).

MCO data suggests that about 33 cases of RMSF go

unreported per year in TN (P < 0.001). Three (3) cases of babesiosis were
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discovered using claims data, a significant finding as this disease has never been
reported in Tennessee. Significant spatial and temporal variations in disease
rates were present (P < 0.001).

This study successfully demonstrates the

usefulness of administrative claims data in the tracking and reporting of zoonotic
diseases.
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INTRODUCTION
Notifiable diseases are infectious diseases for which regular, frequent, and
timely reporting of individual diagnosed cases aids in prevention and control (e.g.,
Lyme disease, giardiasis, salmonella) (GAO 2004; CDC NNDSS 2010). In 1961,
the Centers for Disease Control and Prevention (CDC) was given oversight
responsibility for compiling and publishing weekly morbidity statistics for listed
notifiable diseases through the Morbidity and Mortality Weekly Report (MMWR).
Public health officials from state health departments collaborate annually with the
CDC to determine which diseases should be listed. This disease surveillance
effort, the National Notifiable Disease Surveillance System (NNDSS), is one of
the oldest surveillance systems in the United States (US). Reporting of disease
cases by health care providers and laboratories is currently mandated only at the
state level and therefore can vary from state to state (Koo and Wetterhall 1996;
CDC NNDSS 2010).
In 2009, there were over 7,000 cases of notifiable communicable diseases
reported to the Tennessee Department of

Health Communicable and

Environmental Disease Services (TDH CEDS 2009).

This is over twice the

number of notifiable diseases reported in 2000 (TDH WebAim 2010). Though
state regulations or contractual obligations may require the reporting of certain
diseases, traditional passive surveillance initiated by the diagnosing clinician can
be burdensome, incomplete, and delayed (Doyle et al. 2002).

Thus

underreporting of diseases exists as not all diagnosed or suspected cases are
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reported by health care providers (Marier 1977; Meek et al. 1996; Young 1998;
Koo and Caldwell 1999; Figueiras et al. 2004), and can vary by physician
specialty (Campos-Outcalt et al. 1991). Many health care providers may not
understand the importance of public health surveillance, and generally how,
when, why, and what to report (Koo and Caldwell 1999; Figueiras et al. 2004).
Health insurance plans could play a major role in the reporting of
infectious diseases (Rutherford 1998; Koo and Caldwell 1999).

Medical

encounter data are recorded within the healthcare system every time a patient
visits their doctor or hospital for a medical service, fills a prescription medicine, or
seeks consultation from a clinician. When seeking reimbursement from a health
plan for the medical services performed, medical encounter data is captured via
an insurance claims form completed by the physician performing the services,
and then is submitted to the health plan. Therefore, all claims with medically
diagnosed cases being filed to a health plan are captured electronically in the
plan’s data warehouse.

Considering more than 253 million Americans have

health insurance and will most likely utilize that service when needed (DeNavasWalt et al. 2010), the administrative data captured from a medical encounter
could serve as a useful source in the tracking of diagnosed infectious diseases.
This study examines the feasibility of using administrative claims data in the
analysis and tracking of infectious zoonotic diseases by comparing medically
diagnosed cases of zoonotic infections extracted from administrative claims data
to zoonotic cases reported to the Tennessee State Health Department. The level
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of underreporting is estimated for five tick-borne (Lyme disease [LD], babesiosis,
ehrlichiosis, Rocky Mountain spotted fever [RMSF], tularemia) and 2 mosquitoborne (West Nile virus, La Crosse viral encephalitis) diseases known to occur in
the southeastern US. The general research hypothesis is that incidence rates
from the state health department are underrepresented when compared to actual
diagnosed claims information.

METHODS
Study Area
Disease cases known to occur for residents living within the state
boundaries of Tennessee were studied.

For the purposes of this study,

Tennessee is considered a southeastern state and is approximately bounded
within the southernmost west coordinate (-90.309200, 34.995800) to the northern
most east coordinate (-81.646900, 36.611900). Approximately 6.3 million people
live within the 95 counties, and they have a median age of 37 and median
income of $43,600. Ninety-three (93) percent of the state population lived in the
same residence or same county as they did one year prior (US Census Bureau
2009).

Of the state’s approximately 10.9 million hectares, 5% is considered

federal lands, 3% water area, 9% non-federal rural, and the remaining 83% is
non-federal non-rural lands (USDA 2000). Estimated land cover percentages for
the state are as follows: open water (2.7%), forested wetland (3.0%), nonforested wetland (0.4%), grassland/pasture (37.2%), cropland (5.8%), upland
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deciduous forest (40.6%), upland mixed forest (4.4%), upland coniferous forest
(3.6%), urban/developed (1.9%), and non-vegetated (0.2%) (Tennessee Wildlife
Resources Agency 1997).

Disease Case Data
Disease occurrence data within the proposed study area of Tennessee
were collected from 2 separate data sources and tested for statistical differences.
The first data source was electronic administrative medical claims data obtained
from a large southeastern managed care organization (MCO) located in
Tennessee.

This MCO insures approximately 60% of the entire state’s

population. All medical claims having a primary or secondary arthropod-borne
disease diagnosis code of interest (see below) were extracted for the January 1,
2000–December 31, 2009 time period.

Allowed claims (i.e., non-voided and

approved for payment) having one of the following diagnosis codes were retained
for study:
Tick-Borne Diseases:
•

Babesiosis (ICD-9 code: 088.82)

•

Borreliosis - Lyme disease (LD) (ICD-9 code: 088.81)

•

Ehrlichiosis - human monocytic ehrlichiosis (HME) (ICD-9 code: 082.41)

•

Rickettsiosis - Rocky Mountain spotted fever (RMSF) (ICD-9 Diagnosis
Code: 082.0)

•

Tularemia (ICD-9 code: 021)
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Mosquito-Borne Diseases:
•

La Crosse viral encephalitis (LACV) (ICD-9 code: 062.5)

•

West Nile virus (WNV) (ICD-9 code: 066.4)

These diseases were selected because they are known to occur within the
southeastern US (CDC NCEZID 2010) and they provide a mix of relatively
abundant cases (e.g., borreliosis, rickettsiosis) to very rare cases (e.g.,
babesiosis, tularemia) to study. Using the MCO database, any patient receiving
medical services for one of the selected diseases prior to the start of the study
period (January 1, 2000) or after the study period (December 31, 2009) was
removed from the analysis. To best ensure the diagnosis for the patient was in
fact their first diagnosis, only the first recorded diagnosis date for each patient
was retained.

Any subsequent claims for the patient were removed and not

considered in this study.

This analysis utilized the exact diagnosis code for

disease identification and served to represent the minimum estimation (i.e., lower
limit) of incidence according to MCO data.
The second data source was an extract provided by the TDH, Center for
Environmental and Communicable Diseases detailing all notifiable “confirmed” or
“probable” disease cases reported to the state of Tennessee during the study
period (TDH WebAim 2010). This resulted in a comparison of medically
diagnosed cases to CDC confirmed or probable disease cases. For example, a
medical diagnosis for LD should be based on an individual’s history of possible
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exposure to ticks that carry LD, the presence of typical signs and symptoms, and
the results of blood tests. CDC case definitions for LD are as follows:
•

Confirmed Case – A case of erythema migrans (“bulls-eye” rash) with
known exposure, or a case of erythema migrans with laboratory evidence
of infection and without a known exposure, or a case with at least one late
manifestation that has laboratory evidence of infection.

•

Probable Case – Any other case of physician-diagnosed LD that has
laboratory evidence of infection.

The comparison between data sources can be made because of the extraction of
medical claims with the specific ICD-9 diagnosis code, not a generic root-level
code.

Thus it is assumed that if a clinician codes at this detail, they have

evidence to support the diagnosis beyond suspicion.

Furthermore, this very

difference and ambiguity is the main intent of the study, which is to compare the
difference between state reported incidence rates and medically diagnosed case
rates to determine if claims data could support the current surveillance system.
Because TDH serves as the compiler of all data sources to the state level, these
data represent a theoretically complete set of reported cases for the state. The
state data detail what the event was (e.g., West Nile virus), when it occurred (i.e.,
event date), and the county of residence for the infected person (i.e., county
name).
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Count Adjustment for MCO Data
Previous unpublished internal work with MCO data indicates that ICD-9
coding errors can exist in the data.

For example, a patient had a claim

containing exactly 1 line item for Enteric tularemia (ICD-9 code: 0211). This line
item was part of a larger medical claim containing many other occurrences of
70211, which is the ICD-9 code for “Inflamed seborrheic keratosis.” This was an
obvious miscode in the system and cause for data validity concerns. Further,
tularemia cases were evenly distributed throughout the year. This is unexpected
as this disease is quite seasonal in nature, occurring in peaks during the summer
months (Boyce 1975). Exact quantification of this error type is difficult, if not
impossible, as it requires manually reviewing tens-of-thousands of line items of
data to check for ICD-9 coding errors, and judgment could in part be subjective.
In addition, no known work exists on this subject, so references are unavailable
on the number of line items needed to ensure validity. Therefore, an adjustment
factor was employed based on the number of line items a patient had for a given
disease in the MCO system. Rather than developing an empirical filter upon
which to remove these types of claims, it was decided to create a threshold value
and apply this to disease cases to remove any cases where the medical claim
did not have at least 3 separate line items with the same diagnosis code. This
could obviously remove valid cases that contain less than 3 line items, but most
likely would remove all cases in error as someone would have to make 3 errors
on the same claim record.

Thus, the MCO rates may in fact be
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underrepresented because of this adjustment. All results and analyses use this
adjustment applied to the MCO data.

Data Aggregations
For each of the seven diseases, the number of cases was aggregated per
county per year separately for TDH and MCO data. Because each data source
had different populations from which case information was drawn, raw counts
could not be fairly compared.

Therefore, the denominator difference was

adjusted by including population counts in all models. For TDH data, yearly
county level population estimations were provided by the Tennessee Department
of Health-Division of Health Statistics. Historical population counts (i.e., plan
membership) by county were not known for MCO data and were therefore
estimated using an overall monthly adjustment factor. This was done by first
calculating total MCO membership enrollment for each month of the study period
(this served as the denominator). Next, the total number of medical claims filed
for each month of the study period was calculated (this served as the numerator).
The adjustment factor was a monthly ratio of medical claims to membership. The
next step was to use this monthly adjustment factor to derive a membership
estimate per county per month for the study period. Medical claims capture the
county of residence of the member, therefore an estimated monthly county level
population was calculated by dividing the total number of medical claims filed by
MCO members within a given month and county by the overall monthly
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adjustment factor. For example, if in January 2000 there were 10,000 active
members enrolled in the MCO health plan, and 2,500 filed a claim in that month,
then the January 2000 adjustment factor is 25% (i.e., 2500 / 10000). If County A
had 400 members file claims during January 2000, then the monthly adjusted
population count for County A would be 1,600 (i.e., 400 / 0.25).

MAP At = m At / a t

Equation 1: Monthly Adjusted Population Counts

where
MAP At = monthly adjusted population for County A at time t (time t is
denoted as the month and year in question)
m At = number of members enrolled in the MCO that reside in County A at
time t
at = statewide adjustment factor at time t given by at = M t / C t where
M t = total number of members enrolled in the MCO at time t
C t = total number of members that filed a claim during time t

The same monthly adjustment factor was applied to all counties for each
respective month, and therefore this approach assumes spatial homogeneity of
claims submissions. This process was validated by comparing this method to
known current membership levels and showed the median inflated error rate to
be approximately 1,768 members, or about a 17% over-adjustment. Therefore,
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incidence rate estimates from MCO could be underrepresented due to this
method because the denominators are inflated.

Statistical Analyses
To estimate if and to what extent underreporting of notifiable diseases
exist, a randomized control block design was employed within a generalized
linear mixed model (GLMM) approach to compare TDH and MCO case counts.
These models are particularly useful in estimating trends in disease rates and
where the response variable is not necessarily normally distributed (Salah et al.
2007; SAS® 2008). Input values into the models included a yearly (n = 10)
county (n = 95) case total, which produced 950 observations for each data
source. Separate models were built for each disease, and the response variable
of interest was disease counts assumed to be Poisson distributed with a logtransformed population count as an exposure offset.

Disease counts were

expected to vary by county (i.e., spatial heterogeneity) due to varying population
denominators, socio-economic factors, and varying geographic and habitat
characteristics (Kalluri et al. 2007; Wimberly et al. 2008; Winters et al. 2008;
Yang et al. 2009). Therefore, county was used as a blocking factor to remove
the expected county-to-county variability when comparing TDH to MCO values.
Space (county) was considered a random effect, while time (year), data source
(MCO vs. TDH), and a time*data source interaction were considered fixed effects.
Fixed effects were examined for statistical significance using the F-test with an
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alpha level of 0.05. Variability in case counts across counties was tested using a
covariance test within the GLMM procedure. SAS® Enterprise Guide version 4.2
and SAS/STAT version 9.3 were used for all analyses (SAS® 2008).
Seasonality profiles were created for each disease and visually compared
between data sources.

These profiles detail the percentage of all recorded

cases by month (January-December) for the entire study period to illustrate in
which months the disease is most prevalent.

This was done for exploratory

purposes to see the relationship between recorded event dates from the state
and the date of service that patients seek medical care.

RESULTS
Overview
Approximately 58,385,858 medical claims were filed during the 2000-2009
study period. Of these, 6,638 patients had a medical claim with a primary or
secondary diagnosis for one of the 7 described arthropod-borne diseases. After
removing invalid claims (patients without at least 3 separate ICD-9 entries for the
disease, patients with claim dates starting or ending outside of the time period,
duplicate patient entries, and patients having non-unique disease coding issues
[e.g., code for RMSF and LD on the same claim]), 1,654 unique cases were
distributed across the 7 diseases of interest and remained for study.

The

average age of patients having one of the described diseases was 37.3 (SD:
19.84; SE: 0.49), and 53.2% were female. Proportion of female patients was
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higher in the mid- to late-age groups (aged 15-60 years).

The age/gender

distribution for patients with a disease is comparatively different from the
population as a whole. In the overall MCO member population, irrespective of
disease, the distribution of males is higher compared to females across all age
groups over 15 years old (Figure 2-1).
The majority of disease cases were LD (n=903; 55%), followed by RMSF
(n=661; 40%). The remaining 5 diseases made up the residual 5% of disease
cases (Figure 2-2). Three (3) cases of babesiosis were found within the MCO
claims data, specifically within Davidson, Lincoln, and Washington Counties.
Average ages varied within each disease type. On average, patients diagnosed
with LACV were much younger than the other diseases (Figure 2-3). Gender
distributions varied by disease. Lyme disease appears to be diagnosed more in
females, while LACV was diagnosed more often in males (Figure 2-4).

Comparison of Medical Claims Case Data to State Reported Data
To determine if and to what extent possible underreporting occurs, MCO
case data was compared to the TDH data set for the entire study period (i.e.,
“data source” comparison). Raw per100k disease rates using the MCO data
source appear higher for LD, babesiosis, RMSF, and tularemia. HME and LACV
rates are higher from the TDH data source, and WNV rates are equal. However,
results from the general linear mixed model suggest that only LD and RMSF
values are statistically different, as all other models did not converge (Table 2-1).
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The average yearly number of medically diagnosed cases of LD from MCO data
were 7.7 times higher those reported to the state (F = 835.44; P < 0.0001). LD
rates significantly varied over the 10 year study period (F = 2.08; P = 0.0283) and
there was a significant temporal interaction with year*data source (F = 2.84; P =
0.0026). Based on the residual pseudo-likelihood, a tests of covariance suggests
there is significant spatial variation of LD cases across the state (χ2 = 84.8; P <
0.0001). The average yearly number of medically diagnosed cases of RMSF
from MCO data were 1.24 times higher than those reported to the state (F =
14.45; P = 0.0001). RMSF disease rates significantly varied over the 10 year
study period (F = 14.82; P < 0.0001), and there was a significant temporal
interaction with year*data source (F = 10.14; P < 0.0001).

There is also

significant spatial variation of RMSF case across the state (χ2 = 1135.01; P <
0.0001).
Temporal trending indicates the aforementioned per 100k rate differences
varied from year to year, and MCO rates were not consistently higher throughout
the entire study period. LD rates from MCO were consistently higher than TDH
rates ( Figure 2-5).

TDH indicated no evidence of babesiosis but MCO data

indicates 3 separate cases in years 2004, 2005, and 2009 (Figure 2-6). RMSF
rates from TDH were lower than MCO rates from 2000-2005, but increased
beyond MCO for all years afterwards except 2008 (Figure 2-7). TDH rates for
HME were consistently higher than MCO (Figure 2-8). Tularemia rates were
much higher in MCO data for years 2000-2004, and then rates became
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approximately equal from 2005-2009 (Figure 2-9). LACV rates for TDH were
higher from 2000-2004, then fluctuate afterwards (Figure 2-10). TDH and MCO
rates for WNV follow similar patterns, with TDH rates being slightly higher (Figure
2-11).
Monthly aggregated data show the seasonality of these diseases (Figure
2-12; Figure 2-13; Figure 2-14; Figure 2-15; Figure 2-16; Figure 2-17) (NOTE:
babesiosis not shown due to non-representation in TDH data). Overall, the tickborne diseases were more prevalent during May – August, whereas the
mosquito-borne illnesses were most prevalent during August – October. With the
exception of tularemia, the seasonal data was relatively consistent between the
two data sources. A time lag is evident throughout the seasonal graphs, where
MCO data is lagging behind the TDH data. The seasonality relationship between
LD and RMSF across the entire study period for MCO data shows RMSF has
sharper peaks suggesting cases are relatively more concentrated in the summer
months (Figure 2-18).

DISCUSSION
Administrative medical claims data is an important resource for research
and surveillance of chronic diseases (Yiannakoulias et al. 2009).

Results

suggest administrative data could be a valuable resource in the tracking and
reporting of infectious zoonotic diseases. The overwhelming majority of cases of
LD and RMSF cases within the MCO data source was expected and supports the
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findings of others (GER 2004; CDC NCEZID 2010). This study suggests LD
rates reported to the state are well below that of MCO administrative data, and
the actual statewide prevalence rate over the study period may be 3.8 per 100k,
rather than 0.49 as reported by TDH statistics. This equates to an approximate
7.7 fold difference over the entire study period, resulting in an additional 1,956
cases above the 292 reported to TDH. This suggests that, on average, about
196 cases of LD go unreported each year in Tennessee. This supports the body
of evidence suggesting LD is underreported, possibly up to 12-fold in some areas
(Meek et al 1992; Coyle et al. 1996). Though these diseases are required to be
reported to the health department through the National Notifiable Disease
Surveillance System, reporting is a voluntary process. It is known that many LD
cases are incomplete, unavailable, and not reported to the CDC (Bacon et al.
2008). Fines associated with non-reporting of diagnosed cases are relatively low
and therefore provide little incentive to do so (MCO internal communication).
However, the process of estimating a true prevalence rate is difficult, because
there is also evidence suggesting LD cases are over-reported in areas that are
not endemic for the disease (Rosen 2009), possibly due to misdiagnoses (Steere
et al. 1993; Svenungsson and Lindh 1997) and having similar clinical symptoms
as other diseases such as Southern Tick Associated Rash Illness (STARI)
(Moncayo 2006; Rosen 2009).

Additionally the deer tick (Ixodes scapularis),

which is the primary vector of Lyme disease, is rarely found in Tennessee
(Moncayo 2006; Rosen 2009), thus providing biological evidence of over-
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estimating the disease. This conflicting evidence supports the need for further
investigation into integrating data sources.
RMSF has been a reportable illness since the 1920s. RMSF rates were
slightly higher according to the MCO data, and suggest the actual number of
cases in the state could have been 3.1 per 100k rather than 2.5 (an average
difference of approximately 33 more cases per year). RMSF is the most severe
and frequently reported tick rickettsial disease in the US (CDC NCEZID 2010).
Tennessee is one of the top 5 states for RMSF transmission, accounting for
approximately 12% of cases nationwide. As with LD, the number of RMSF cases
may be underreported due to vague and/or asymptomatic infections (Lacz et al.
2010), and despite frequent laboratory testing and reports of RMSF, the true
incidence in Tennessee is unknown (Moncayo et al 2010).

Indirect

immunofluorescence assay (IFA) serologic testing is used by the CDC and most
state laboratories, though this test commonly produces false positive and false
negative results (GER 2004) and therefore cannot always provide definitive proof
of RMSF in the early symptomatic phase.

Additionally, diagnostic levels of

antibodies do not appear until a week or more after onset of symptoms, thus
making early detection difficult.

Prospective active surveillance for RMSF in

regions where the disease is hyperendemic suggests that as many as 50% of all
cases (including confirmed but unreported deaths due to RMSF) are missed by
passive surveillance mechanisms (Wilfert et al. 1981).
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Overall, disease incidence rates were higher using administrative data for
all tick-borne diseases except HME (ehrlichiosis). The state reported a nearly 3fold increase in HME cases from 2007 to 2008. Cases in the neighboring state of
Georgia have increased dramatically since being reportable in 1999 (GER 2004)
and recent expansion of the lone star tick has increased cases in the New
England area (CDC MMWR 1998; ALDF 2006).

HME rates may be

comparatively lower in MCO data because clinical diagnosis is difficult due to
misdiagnoses and limitations of confirmatory testing. Diagnoses are often made
before laboratory confirmation is available.

HME in Tennessee is under

recognized and not routinely tested (Moncayo 2006). Patients will usually seek
medical care when initially experiencing vague and possibly mild flu-like
symptoms, prior to the presence of classical diagnostic signs and symptoms
(GER 2004). The large deviation in HME cases between MCO and TDH data
warrant further investigation into diagnosing patterns because it is apparent the
disease is being reported to the state, but not necessarily recorded in the ICD-9
medical claims system as the specified coding level examined during this study.
Though statistical testing of babesiosis was inconclusive due to the small
sample size, MCO data indicated at least 3 cases of babesiosis were diagnosed
in Tennessee during the 2000-2009 study period. This is of interest because
babesiosis has never been reported in the state, and was only recently discussed
at the 2010 International Conference on Emerging Infectious Diseases
Conference, whereby the authors suggested they had discovered the first
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diagnosed case in Tennessee in 2009 (Mosites et al. 2010). These authors are
now attempting to identify animal reservoir hosts and tick vectors. Data from the
MCO could aid in this effort, and suggest that at least 2 other cases occurred
prior to this finding.
The large noted differences in tularemia cases for the 2000-2004 time
period and then convergence of values for the remaining study period was
unexpected. An outbreak of tularemia has occurred in Tennessee in the distant
past (Warring and Ruffin 1946), therefore it is possible that an isolated acute
outbreak occurred but went unreported (NIAID 2008). It is also plausible this
increase was related to bioterrorism because F. tularensis, the causative agent of
tularemia, can be spread via aerosol transmission.

Since the 2001 terrorist

attacks at the World Trade Center, there is heightened awareness of this disease
(Altman 2002; Palmore et al. 2002) and therefore may explain the spikes in
diagnosed cases.
Patients diagnosed with La Crosse viral encephalitis were much younger
than all others with a diagnosed zoonotic disease (median age: 8), and is
consistent with the findings of others (Erwin et al. 2002). Due to sample size, no
definitive conclusion for comparing the TDH with MCO data was reached.
However, the data suggest more cases were reported than diagnosed for years
2000-2003. The relationship reversed from 2006-2009, suggesting more cases
were diagnosed than reported. LACV is the predominant virus of the California
serogroup, which is made up of other viral infections including St. Louis

46

encephalitis, Eastern/Western equine encephalitis, and other unspecified
mosquito-borne viral encephalitis. Diseases in this serogroup can present with
similarities. Thus, uncertainty around an exact diagnosis of LACV is possible
because non-diagnosed cases may have failed to develop antibodies or available
testing procedures are not sufficiently sensitive (Erwin et al. 2002). As previously
mentioned, examination of specific ICD-9 codes shows it is possible some cases
went undetected due to variation in clinician coding practices.
West Nile virus rates from the MCO data followed a similar temporal
pattern to TDH reported cases, though actual MCO numbers were slightly lower
and statistical testing was inconclusive due to sample size. As with LACV, the
clinical diagnosis of WNV (ICD-9: 066.4) falls within a larger more generic root
ICD-9 category of “066: Other arthropod-borne viral diseases.” This phase of the
study examined only those cases with specific ICD-9 codes, and it is therefore
possible that many cases reported to the state were diagnosed at the root level,
rather than the actual ICD-9 code. To better understand the impact this may
have on rates, I post-hoc examined per 100k rates at the root ICD-9 level for
WNV and determined rates averaged over the study period were 52 times higher
(4.37 vs. 0.08) when using the root diagnosis code compared to the specific ICD9 diagnosis. This suggests physicians are far more likely to code at the root level,
versus the more specific code level. Further work in this area is needed.
Zoonotic diseases are very seasonal in nature, mainly due to the temporal
dynamics of the vectors’ life cycles and population densities of intermediate hosts.
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For example, mid-summer peaks in Lyme disease incidence suggest tick nymphs
are the life stage most responsible for transmitting infections to humans (Killilea
et al. 2008). Additionally, infection rates may be higher in the summer months
because the general public spends more time out of doors during this time, thus
increasing the likelihood of exposure.

Results from this study suggest

administrative data and actual reported cases from TDH follow similar seasonal
distributions patterns. TDH data cannot be compared directly to MCO on a case
by case basis (i.e., cannot match a patient record to a state reported case).
MCO prevalence data slightly lagged behind TDH by approximately a month or
two. This is expected because the TDH event date represents the estimated
date of exposure, whereas MCO data represents the date when the infected
individual sought medical care. It is known that symptoms of a zoonotic disease
can develop days or even months after a bite (CDC NCEZID 2010). This lag
phenomenon further confirms the usefulness of MCO data in tracking zoonotic
infections, as it provides an estimate of the time from exposure to treatment.
This seasonal overlapping of data serves as both visual and quantitative
confirmation that MCO data are in fact a viable source for detecting zoonotic
infections.

That is, this correlation between data sources can serve as an

indication that each data source is measuring similar events.
Limitations in study include the inability to empirically filter out claims in
error. Even though the data were filtered to include only cases with at least 3 line
items, there still exists the possibility of claims coding errors. This filtering also
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limits the ability to potentially estimate the true rate, because valid claims might
be removed using this filtering process. Treatment for these diseases is also not
necessarily consistent between health care providers, so this introduces
complexity in any attempts to develop an empirically based claim line item count
algorithm. Uncertainties surrounding the diagnosis and reporting of these cases
suggest such trends must be interpreted with caution.

Historical population

counts by county were not known for MCO data and were therefore estimated,
and this estimation may not be without error. There was no control for patients’
enrollment time in the plan, so it is possible that a patient’s claims records are
incomplete. For five of the seven studied diseases, statistical testing was not
possible due to sample sizes. However, it can be argued that statistical testing is
not necessarily required because data for both sources were not drawn from a
sample and represent the population. Therefore, any noted differences are in
fact real differences. We are further limited by the inability to relate, via a patient
identifier, a medically diagnosed case to a CDC defined “confirmed” or “probable”
case.

A patient could be coded with LD in the MCO claim system without

necessarily having a laboratory confirmed diagnosis, or a physician could report
a confirmed case without laboratory confirmation if the patient presented with
erythema migrans and was recently in an endemic county (CDC 1995). Only one
other study has examined the differences between administrative data and
notifiable disease data (Yiannakoulias and Svenson 2009), and they arrived at
the same conclusion that administrative health data may be insufficiently precise
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without laboratory confirmation. Both studies conclude that administrative data
could enhance the current passive surveillance registry system.

CONCLUSIONS
Zoonotic diseases in Tennessee, particularly LD and RMSF, may be
significantly underreported to the state health department within the current
passive system. Administrative medical claims data suggest that approximately
200 cases of Lyme disease and 30 cases of Rocky Mountain spotted fever go
unreported each year in Tennessee. Medical claims data show babesiosis may
have been present in the state 8 years prior to what is currently thought to be the
first reported incident. This study successfully demonstrates the usefulness of
administrative claims data in the tracking and reporting of zoonotic diseases.
In the past 10 years, the number of officially reported cases of tick-borne
diseases in Tennessee has increased (e.g., from 0 officially reported cases of
ehrlichiosis in 1995 to 74 in 2008, and from 0 reported cases of RMSF in 1995 to
232 in 2008) (TDH WebAim 2010). State and local public health officials rely on
health care providers, laboratories, and other public health personnel to report
the occurrence of notifiable diseases to state and local health departments (CDC
1997).

Missing from this statement is health plans and the data they could

provide to state and national surveillance efforts. Without such data, trends
cannot be accurately monitored, unusual occurrences of diseases might not be
detected, and the effectiveness of intervention activities cannot be easily
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evaluated. Reporting methods using administrative data and CDC surveillance
are similar in that both represent the location of the disease based on the
resident county of the infected individual, not exposure. This should help control
for differences in data gathering methodologies. Though dates may differ, both
data sources also capture a temporal component, where TDH reports the
estimated exposure date and MCO data reports the data the infected individual
sought medical treatment.

However, specific spatio-temporal differences of

these two data sources are not known and further work examining these
attributes is warranted.
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Table 2-1: Summary statistics and results from general linear mixed models for
yearly per 100k disease incidence comparisons between MCO and TDH data
MCO
Yearly
mean
SD

TDH
Yearly
mean
SD

F-value

Lyme Disease

3.76

0.80

0.49

0.13

835.44*

Babesiosis†

0.01

0.02

0.00

0.00

-

Rocky Mtn. spotted fever
Human Monocytic
Ehrlichiosis†

2.75

0.46

2.32

1.17

14.45*

0.06

0.06

0.59

0.34

-

Tularemia†

0.19

0.21

0.05

0.04

-

La Crosse Viral Encephalitis†

0.04

0.05

0.10

0.13

-

West Nile Virus†

0.08

0.09

0.08

0.12

-

* Significant at P < 0.05
†

Mixed-models did not converge
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Figure 2-1: Distribution of gender across age groups for patients with one of the
described diseases (lines) compared to the entire MCO population (columns)
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Figure 2-2: Percent distribution of medically diagnosed zoonotic diseases in
Tennessee for the 2000-09 study period
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Figure 2-3: Mean (white square) and standard errors (bars) of patient age across
disease type
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Figure 2-4: Distribution of gender across disease type
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Figure 2-5: Temporal comparison of Lyme disease incidence rates using MCO
medical claims data and Tennessee State Health Department (TDH) reported
data
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Figure 2-6: Temporal comparison of babesiosis disease incidence rates using
MCO medical claims data and Tennessee State Health Department (TDH)
reported data
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Figure 2-7: Temporal comparison of RMSF disease incidence rates using MCO
medical claims data and Tennessee State Health Department (TDH) reported
data
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Figure 2-8: Temporal comparison of HME disease incidence rates using MCO
medical claims data and Tennessee State Health Department (TDH) reported
data
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Figure 2-9: Temporal comparison of tularemia disease incidence rates using
MCO medical claims data and Tennessee State Health Department (TDH)
reported data
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Figure 2-10: Temporal comparison of La Crosse viral encephalitis (LACV)
disease incidence rates using MCO medical claims data and Tennessee State
Health Department (TDH) reported data

67

0.40

Annual Incidence Rate (per 100,000)

0.35

0.30

0.25

0.20

0.15

0.10

0.05

0.00

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

TDH

0.00

0.00

0.19

0.36

0.00

0.03

0.18

0.02

0.00

0.00

MCO

0.00

0.00

0.05

0.18

0.00

0.07

0.15

0.28

0.08

0.04

Year

Figure 2-11: Temporal comparison of West Nile virus (WNV) disease incidence
rates using MCO medical claims data and Tennessee State Health Department
(TDH) reported data
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Figure 2-12: Comparison of the seasonal distribution of Lyme disease cases for
MCO data (diagnosis date according to medical claims) versus TDH data
(estimated date of exposure according to state records)
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Figure 2-13: Comparison of the seasonal distribution of Rocky Mountain spotted
fever cases for MCO data (diagnosis date according to medical claims) versus
TDH data (estimated date of exposure according to state records)
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Figure 2-14: Comparison of the seasonal distribution of human monocytic
ehrlichiosis cases for MCO data (diagnosis date according to medical claims)
versus TDH data (estimated date of exposure according to state records)
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Figure 2-15: Comparison of the seasonal distribution of tularemia cases for MCO
data (diagnosis date according to medical claims) versus TDH data (estimated
date of exposure according to state records)
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Figure 2-16: Comparison of the seasonal distribution of La Crosse viral
encephalitis cases for MCO data (diagnosis date according to medical claims)
versus TDH data (estimated date of exposure according to state records)
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Figure 2-17: Comparison of the seasonal distribution of West Nile virus cases for
MCO data (diagnosis date according to medical claims) versus TDH data
(estimated date of exposure according to state records)
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Figure 2-18: Seasonality of Lyme disease (solid line) compared to Rocky
Mountain spotted fever (dashed line) over the entire 2000-09 study period using
MCO administrative medical claims data

CHAPTER 3

SPATIO-TEMPORAL DIFFERENCES OF ARTHROPOD-BORNE INFECTIONS
USING ADMINISTRATIVE MEDICAL CLAIMS DATA AND STATE REPORTED
SURVEILLANCE DATA

ABSTRACT
When considered separately, notifiable disease registry systems and
administrative medical claims data have positive and negatives attributes within
disease surveillance efforts. Combined however, these data sources could
provide a more complete source of information. Using a spatio-temporal scan
statistic, zoonotic case information derived from a state registry system (TDH)
was compared with administrative medical claims information derived from a
managed care organization (MCO) to statistically validate when and where these
data sources differ. Study observations included case information for four tickborne (Lyme disease [LD], ehrlichiosis, Rocky Mountain spotted fever [RMSF],
tularemia) and 2 mosquito-borne diseases (West Nile virus [WNV], La Crosse
viral encephalitis [LACV]) known to occur in Tennessee during 2000-09. A total
of 103 clusters were detected indicating when/where case volume was greater
than expectation. Of these, 9 were statistically significant (P<0.05) with 7 from
TDH data.

Considering only the significant clusters, there was no spatial or

temporal overlapping between data sources. Findings suggest MCO data and
TDH registry data each add unique important disease information. This study

76

further supports the need to integrate administrative and clinical registry data
sources in order to provide a more comprehensive set of case information.
INTRODUCTION
Syndromic surveillance is the identification of disease indicators based on
cases yet to be confirmed through, for example, laboratory results.

Case

information is usually defined through administrative medical data sources such
as emergency room reports and hospital inpatient data.

The intent of

surveillance is to detect disease outbreaks quickly in order to increase response
time (Mandl et al. 2003; Kuldorff et al. 2005). Until recently, little emphasis has
been given to the importance in using administrative medical claims data for
research in and surveillance of communicable diseases (Yiannakoulias and
Svenson 2009; Chapter 2). However, because of the need for rapid outbreak
detection, administrative medical data as a supplemental resource for disease
surveillance is gaining more attention (Buckeridge 2005; Yiannakoulias and
Svenson 2009).
Notifiable diseases are infectious diseases for which regular, frequent, and
timely reporting of individual diagnosed cases aids in prevention and control.
The National Notifiable Disease Surveillance System (NNDSS), with oversight
from the Centers for Disease Control and Prevention (CDC), serves as the
nation’s comprehensive source of data on reportable notifiable diseases (CDC
NNDSS 2010). When considering using notifiable disease registry systems and
administrative medical claims data in surveillance efforts, both data sources have
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positive and negatives attributes.

Disease registry systems provide case

information for health care organizations and providers, public health officials,
government and regulatory agencies, and others concerned with information
about potentially preventable diseases.

However, significant underreporting of

notifiable diseases exists even though state regulations or contractual obligations
may require it (Marier 1977; Meek et al. 1996; Young 1998; Koo and Caldwell
1999; Bailey et al. 2005; Rosen 2009; Yiannakoulias and Svenson 2009; Chapter
2). Further, registry data is often presented at a comparatively more granular
spatial

scale

(e.g., county) compared

to

administrative

medical

data.

Administrative medical claims data may be more comprehensive than disease
registry data but at the expense of potential over-reporting due to misdiagnosis or
premature diagnosing without confirmed laboratory tests, coding errors, and
variability in provider practice patterns. Together though, these two data sources
could provide a valuable combination of information for spatio-temporal
surveillance (Yiannakoulias and Svenson 2009; Chapter 2).
Other than the work presented in Chapter 2, only one other study
examining the differences between administrative data obtained from a health
insurer and notifiable registry data for zoonotic case information is known
(Yiannakoulias

and Svenson

2009).

Both studies

indicate

significant

underreporting of cases, as well as spatial and temporal variation of information
between the two data sources.

Chapter 2 highlights that significant spatio-

temporal differences exist at the aggregated population level. Yiannakoulias and
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Svenson (2009) go on to test for spatio-temporal clustering differences to
specifically highlight where and when statistical separation occurs for Escherichia
coli O157:H7 infections derived from the two data sources.
This study compares information derived from state reported cases of
zoonotic infections with administrative medical claims information derived from a
large southeastern managed care organization (MCO). The analysis presented
in Chapter 2 and is expanded here to compare the spatio-temporal clustering
information generated from these two data sources. The intent is to statistically
validate when and where these data sources differ by examining case
information on four tick-borne (Lyme disease [LD], ehrlichiosis, Rocky Mountain
spotted fever [RMSF], tularemia) and 2 mosquito-borne diseases (West Nile virus
[WNV], La Crosse viral encephalitis [LACV]) known to occur in Tennessee.

METHODS
Study Area
The study area for this project was described in Chapter 2, but briefly,
Tennessee is considered a southeastern state and is approximately bounded
within the southernmost west coordinate (-90.309200, 34.995800) to the northern
most east coordinate (-81.646900, 36.611900).
consists of the 95 counties within Tennessee.
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The spatial sampling unit

Disease Case Data
Case data for the four diseases was extracted from two separate data
sources and compared for spatial and temporal differences.

The first data

source was medically diagnosed cases extracted from a MCO claims data
warehouse. Described earlier in Chapter 2, all medical claims having a primary
or secondary arthropod-borne disease diagnosis code of interest (see below)
were extracted for January 1, 2000-December 31, 2009. Although 3 records of
babesiosis were observed in the MCO database (Chapter 2), no observations
existed in TDH data and this disease was therefore excluded from analyses.
Medical claims having one of the following diagnosis codes were retained for
study:

Tick-Borne Diseases:
•

Borreliosis - Lyme disease (LD) (ICD-9 code: 088.81)

•

Ehrlichiosis - human monocytic ehrlichiosis (HME) (ICD-9 code: 082.41)

•

Rickettsiosis - Rocky Mountain spotted fever (RMSF) (ICD-9 Diagnosis
Code: 082.0)

•

Tularemia (ICD-9 code: 021)

Mosquito-Borne Diseases:
•

La Crosse viral encephalitis (LACV) (ICD-9 code: 062.5)

•

West Nile virus (WNV) (ICD-9 code: 066.4)
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Any patient receiving medical services for one of the selected diseases prior to
the start of the study period (January 1, 2000) or after the study period
(December 31, 2009) was removed from the analysis. For MCO medical claims
data, space and time are represented as the county of residence for the patient
at the time medical services were rendered, respectively.
The second data source was an extract provided by the Tennessee
Department of Health (TDH), Center for Environmental and Communicable
Diseases (CEDS) detailing all notifiable diseases reported to the state of
Tennessee during the study period (TDH WebAim 2010). Because TDH serves
as the compiler of all data sources to the state level, this data represents a
theoretically complete set of reported cases for the state. For TDH data, space
and time are represented as the resident county for the infected person and
when the exposure likely occurred, respectively.

Statistical Analyses
For each data source and disease, a retrospective space-time permutation
analysis was conducted to determine if significant space-time disease clusters
were similar between data sources. The space-time scan statistic methodology
is described in detail in Kulldorff et al. (2005). Briefly, a scan statistic is created
by moving a cylindrical window over each county centroid, where the circular
base represents the size of the search radius space around the centroid and the
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cylinder height represents a pre-defined time duration.

Significant cluster

detection is determined using this scan statistic by creating a relatively infinite
number of overlapping cylinders to define the scanning window, each being a
possible candidate for a disease cluster. Within each cylinder, the actual and
expected number of disease cases, along with a Poisson generalized likelihood
ratio (GLR) is calculated.

Under the Poisson assumption, the generalized

likelihood ratio (GLR) for any given scan window is calculated as:

 c 


 E[c] 

c

 T −c 


 T − E[c] 

T −a
Equation 2: Poisson GLR

I

where
T = total number of cases
c = actual number of cases within the scan window
E[c] = expected number of cases within the window under the null
hypothesis
I = indicator function which is equal to 1 if c > E [c] or 0 otherwise
(Kulldorff 1997)

To detect clusters with high rates, I was set to 1 (i.e., observed value should be
higher than the expected value). Using Monte Carlo simulation (Dwass 1957),
the actual GLR is compared to simulated GLRs within the cylinder. Relative risk
(RR) for a significant cluster is calculated as the observed number of cases
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divided by the expected number of cases.

For clusters where RR > 1, this

indicates the observed number of diseases cases is greater than expectation.
Statistical significance is defined in terms of a p-value, and is computed as
p=R/(S+1), where R is the rank of the GLR for the actual observation and S is the
number of simulated cases. For example, if you simulate 999 cases, you thus
obtain 999 GLR values. You then rank order these 999 GLRs from highest to
lowest, where the highest GLR indicates the highest probability a cluster exists at
that site. You then insert the actual GLR into this rank ordered list, and if the
actual GLR is higher than the 50th highest simulated GLR, then the cluster is
statistically significant at an alpha of 0.05 (i.e., 50 / 999+1). Irrespective of the
actual P value itself (i.e., does not have to be below 0.05), the cluster with the
highest P value is considered the primary cluster and all subsequent clusters in P
value rank order are considered secondary.

This analysis adjusts for any

potential purely spatial and/or temporal variation, does not require a control
comparison, and is most appropriate when information about the population-atrisk is unavailable or irrelevant (Kulldorff et al. 2005).

SaTScan™ software

v9.0.1 (Kulldorff 2010) was used for all cluster detection analysis.

Specific

software settings for these analyses included a retrospective space-time
permutation probability model scanning for areas of high disease incidence, time
aggregation of 1 month, a maximum spatial cluster size equal to 25% of the atrisk population, maximum temporal cluster size equal to 25% of the study period,
a maximum of 999 Monte Carlo replications, and secondary clusters could not
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entirely overlap other previously reported clusters. Maps of significant clusters
were generated using Maptitude™ v5.0 GIS software (Caliper Corporation 2008).

RESULTS
Case volume results for the study period are presented in detail elsewhere
(Chapter 2). Briefly, within the MCO claims data there were 1,651 diagnosed
cases distributed across the six diseases compared to 2,166 TDH registered
cases. Raw count values are less important in this study because the underlying
populations are different, and therefore counts are expected to vary.

More

importantly is the distribution of cases within a data source and the space-time
clustering of these cases.
LD cases contributed to the majority of disease cases for MCO data
(54.7%), while RMSF cases accounted for the majority of TDH cases (64.1%)
(Figure 3-1). Across all six diseases, 103 clusters had a RR score greater than 1,
indicating the observed number of diseases cases was greater than expectation.
Relative risk varied significantly across the diseases, but the largest RR values
are associated with smaller case volume. Of the 103 clusters, 9 were statistically
significant (P<0.05) with 7 from TDH data and 2 from MCO data. Considering
each disease separately and only examining statistically significant clusters,
there was no spatial or temporal overlapping between data sources (Table 3-1).
Spatial and/or temporal overlapping occurred between data sources if
significance was not considered (data not presented).
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Both data sources

produced statistically significant LD and RMSF clusters, while only TDH data
produced a significant WNV cluster. No significant clusters were found for HME,
tularemia, or LACV. A cluster ID was assigned to all space-time clusters in order
to cross-reference information in Table 3-1 to Figure 3-2 – Figure 3-4 for
temporal and spatial cluster maps. The cluster ID is a concatenation of disease,
data source and cluster order. The first letter in the ID denotes the first letter of
the disease (L=Lyme disease; R=Rocky Mountain spotted fever; W=West Nile
virus), the second letter denotes the data source (M=MCO; T=TDH) and the
number represents the cluster order based on relative risk values (1=first;
2=second, etc.). The top portion of Figure 3-2 – Figure 3-4 illustrates the spatial
overlay of the clusters, while the bottom portion indicates the temporal overlay of
the clusters.

DISCUSSION
This study compared the spatio-temporal information of arthropod-borne
zoonotic disease cases derived from two data sources, administrative medical
claims data and a state notifiable disease registry system. No attempt was made
to make case-level comparisons between the data sources. Rather, analyses
were aggregated to the data source scale in order to make generalizations about
spatio-temporal clustering similarities and differences between these two
systems. Unlike the sampling universe in Yiannakoulias and Svenson (2009) in
which nearly all patients are insured by public insurance, our observed values
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(i.e., disease cases) for TDH and MCO are not necessarily independent, nor are
they necessarily non-independent.

MCO cases are not necessarily a pure

subset of the state numbers and vice versa. For example, a patient could have
LD and the diagnosing clinician reports the case to the state. That patient may or
may not be a member of the MCO.

If the patient was a member of the MCO,

this would be both a state case and a MCO case.

If they are a non-MCO

member, this is a state case, but not an MCO case. Conversely, a patient could
have LD and be a MCO member but the diagnosing clinician does not report the
case. This would indicate a MCO case that is not a state case.
MCO cluster LM1 and TDH clusters LT1 and LT2 were statistically
significant LD clusters but did not overlap in space or time. Cluster LT2 had no
radius and was therefore centered on the county centroid.

The outermost

northwest portion of the LM1 cluster was approximately 12 km from cluster LT2,
and the clusters were separated by about 1.5 years in time.

MCO cluster LM1

temporally correlates with earlier MCO findings (Chapter 2) suggesting sharp
peaks in LD rates during the 2002 time period. LM1 and LT1 outer cluster limits
are separated by less than 45 km. Both data sources thus provide valuable
disease case information not captured in one another. No LD clusters occurred
in the western portion of the state. This mostly agrees with the findings of others
reporting detection of Borrelia burgdorferi, the causative bacterium of LD, in the
middle to eastern portions of the state (Haynes et al. 2005; Shariat et al. 2007;
Jordan et al. 2009).

LD clusters were not necessarily confined to summer
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months, unlike the seasonality trends where the majority of cases occurred in the
summer months (Chapter 2). We interpret this finding as the ability of the scan
statistic to adjust for purely temporal abnormalities by testing thousands or even
millions of overlapping space-time clusters (Kulldorff et al. 2005).

That is,

disease surveillance is only effective if you can detect in a timely manner when
case volume is abnormal. If you were to simply compare case volume on a
month by month basis, for example, your results would suggest LD outbreaks
occur in May or June compared to previous months simply because this is when
the disease is most prevalent (Chapter 2). Conclusions could be flawed because
the temporal look-back period is not long enough, nor it is variable as it is in the
scan statistic (Kulldorff et al. 2005).

Thus, after adjusting for temporal case

volume, significant clusters appear throughout a year from both data sources
with no clear pattern. All of this suggests the eastern portion of Tennessee may
be a high-risk area for LD monitoring.
RMSF is the most commonly reported tick-borne disease in Tennessee
(Moncayo et al. 2010). In 2009 there were 1,393 cases reported nationwide, with
184 (13%) occurring in Tennessee (CDC MMWR 2010) making it the 3rd highest
case count in the US. In a study of RMSF disease severity, Tennessee ranked
2nd only to North Carolina in the percentage of fatal RMSF cases (Adjemian et al.
2009). A significantly large RMSF cluster (RM1) was detected from MCO data in
the western portion of the state, centered in Haywood County and extending out
87 km, touching 28 Tennessee counties and completely inscribing 10 counties.
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The center of RM1 was located 105 km from the cluster center of 6 fatal RMSF
cases reported by Adjemian et al. (2009), and was completely inscribed within its
250 km radius. Temporally for RM1, this 6-month cluster coincides with the most
prevalent months (April – October) of infected cases (Chapter 2), with nearly
92% of all MCO cases occurring during this time of year. TDH cluster RT1, RT3,
and RT4 are all located in the middle portion of Tennessee, suggesting this
rather large area should be monitored more closely for RMSF outbreaks. TDH
cluster RT2 in Monroe County is further east than the other TDH clusters, and is
temporally long beginning in May 2003 and lasting 52 months (August 2005).
This long duration temporally agrees with earlier findings (Chapter 2) where TDH
rates began to rise dramatically in 2003 and peaked in 2006. Our findings in the
west agree with the known increased risk of RMSF in western Tennessee
(Adjemian et al. 2009; Moncayo et al. 2010), but go further to suggest the middle
and eastern portions of the state should also be monitored for heightened RMSF
infections. As with LD, statistically significant RMSF clusters for MCO and TDH
did not overlap in space or time, thus providing further evidence to support data
integration.
A significantly high volume of WNV cases occurred in Fall 2003. One year
earlier in August 2002, a significant cluster in Dyer County was detected in TDH
data (WT1), though it went undetected in MCO claims data.
generally agree both temporally and spatially with others.

Our findings

The largest WNV

epidemic ever recorded in US history occurred in 2002, with 4,156 human cases
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and 284 deaths. Shelby County, Tennessee is located 3 counties south of Dyer
County. It has consistently reported the highest number of human WNV cases,
and from 2002 through 2006, 136 human WNV cases were reported to the state
of which 66% occurred in Shelby County (Ozdenerol et al. 2008). Further, high
volumes of laboratory confirmed WNV infections were detected in the Tennessee
Valley area for the July – September 2002 time period in nearby Paris, TN, less
than 35 km from the Dyer County cluster edge (Cupp et al. 2007).
Overall, results are mixed when comparing spatial and temporal clustering
between data sources.

This agrees with the preponderance of evidence

suggesting the need to integrate electronic administrative data with clinical
registry data (e.g., NAHDO; Doebbeling et al. 1999. Virnig and McBean 2001) in
order to provide more comprehensive information than either single source.
Disease surveillance and retrospective health care studies require monitoring of
incidence rates across space and over time. Therefore, sample sizes can be
limited within the space, time, or space-time dimension. For example, less than
2% of all peer-reviewed publications in the journal Ecology were from studies
lasting more than 5 years (Tilman 1989). Because of limited data resources,
public health officials and researchers should make full use of existing data
sources, both administrative and clinical registries. Limited sample sizes can be
inherit in studies covering large geographic areas simply due to logistical and
cost constraints, and therefore the alternative is to reduce the study area and
scope (e.g. Letcher et al. 2002).

However, a small scale spatial study can
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introduce unwanted bias in the results because biological organisms may exhibit
differential responses at different spatial scales (Wiens and Milne 1989;
Zimmerman et al. 2007). Medical claims data are recorded within the healthcare
system every time a patient visits their doctor or hospital for a medical service,
fills a prescription medicine, or seeks consultation from a physician. Of particular
interest is the amount of available data from health plans, as well as the temporal
and spatial granularity of captured data elements from each medical encounter.
Medical claims data contain, among other things, the patient’s ZIP code at the
time of service, date of medical service, and medical diagnosis codes which
describe the reason why the patient is seeking medical care. The geographic
element of a patient’s residence location combined with the date of diagnosis
provides both a spatial and temporal “stamp” of what the patient was exposed to,
and potentially when and where the exposure may have occurred. Health plans
may provide a centralized warehouse of rich data spanning many years,
supporting more large-scale longitudinal disease studies (Roos et al. 1987;
Schull et al. 2006) and surveillance activities.
Our study is not without limitations for some of the reasons outlined in
Chapter 2.

Statistical significance was not reached in all clusters and

insignificance could simply be determined based on our parameter settings within
the SaTScan™ tool (Sugumaran et al. 2009), the chosen spatial scale (Winters
et al. 2008; Lloyd 2010), or limited sample size for certain diseases.
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CONCLUSIONS
Findings suggest administrative claims data offer disease case information
not captured in clinical registry systems and vice-versa, thus supporting the need
for integrating data to provide a more comprehensive data source. Less than
one-third of all US states placed contractual obligations on Medicaid contracts for
MCOs to report communicable diseases (Mauery et al. 2003). Therefore, health
plans themselves could engage in direct reporting of notifiable diseases because
they process the medical claims containing the diagnoses information.
Supplemental reporting of communicable diseases by health plans could
centralize the reporting to health departments or the CDC, thereby expediting the
ability to identify potential disease clusters (Mauery et al. 2003). Medical claims
data may aid in the study and tracking zoonoses as it could be used to improve
both the temporal and spatial scale of study through the use of long-term
longitudinal data covering a large geographic expansion. Additionally, claims
data could supplement the current reporting of notifiable diseases to the CDC.
This effort may help bridge the disease incidence gap created by health care
providers’ underreporting and thus allow for more effective tracking and
monitoring of infectious zoonotic diseases across time and space.
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Table 3-1: Spatio-temporal county-level cluster summary of statistically
significant clusters per data source
Num. Relative
Data Cluster
Cluster Time Period P
County†
of
Risk
Disease
Radius‡ of Cluster value
Source ID*
Cases (RR)**
MCO LM1
Monroe
76.0
1/02-3/04 0.006 68
1.95
Lyme
LT1
Sullivan
92.0
1/09-7/09 0.004 13
5.02
disease TDH
LT2 Cumberland 0.0
7/00-8/00 0.034 4
23.84
MCO RM1 Haywood
86.7 4/09-10/09 0.002 25
3.15
Rocky
RT1
Marshall
0.0 10/00-11/00 0.001 3
347.25
Mountain
RT2
Monroe
67.5
5/03-8/05 0.001 65
2.08
spotted
TDH
RT3
Smith
74.9
5/07-8/08 0.001 119
1.66
fever
RT4 Hickman
52.8 12/05-11/06 0.006 57
2.04
Human
Monocytic
no significant clusters
Ehrlichiosis
Tularemia

no significant clusters

La Crosse
viral
no significant clusters
enceph.
West Nile
TDH WT1
Dyer
67.9
8/02-8/02 0.007 5
6.57
virus
* Refer to Figure 3-2 - Figure 3-4 for cluster ID location and time comparison
†
County location for center of cluster
‡
Radius = 0 indicates cluster is centered on county centroid; Displayed as a dot
on maps.
**
Calculated as the number of observed cases divided by the number of
expected cases
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Percentages of Observed Cases by Data Source
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La Crosse viral
encephalitis
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Figure 3-1: Summary of disease distribution by data sources: managed care
organization (MCO) adminsitrative claims data and the Tennessee Deaprtment of
Health (TDH) notifiable disease registry
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Figure 3-2: Spatial (top) and temporal (bottom) comparison of significant Lyme
disease clusters created using two data sources: managed care organization
(MCO) administrative claims data and the Tennessee Department of Health
(TDH) notifiable disease registry
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Figure 3-3: Spatial (top) and temporal (bottom) comparison of significant RMSF
clusters created using two data sources: managed care organization (MCO)
administrative claims data and the Tennessee Department of Health (TDH)
notifiable disease registry
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Figure 3-4: Spatial (top) and temporal (bottom) comparison of significant WNV
clusters created using two data sources: managed care organization (MCO)
administrative claims data and the Tennessee Department of Health (TDH)
notifiable disease registry
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CHAPTER 4
SPATIALLY EXPLICIT MULTI-SCALE MODELS FOR EXPLAINING THE
OCCURRENCE OF INFECTIOUS ZOONOTIC DISEASES

ABSTRACT
Zoonotic diseases can be transmitted via an arthropod vector, and it is
often of interest to create disease incidence risk maps based on underlying
associative factors within the surrounding landscape of known occurrences. A
major limitation however is the ability to track disease incidence at a meaningful
geographic scale. It has been shown that administrative medical claims data is
useful in the tracking of zoonotic diseases and provides disease case information
at the ZIP code level.

Four separate modeling techniques were compared

(stepwise logistic regression, classification and regression tree, gradient boosted
tree [GBT], neural network [NNET]) to describe the occurrence of 2 tick-borne
diseases known to occur in Tennessee (Lyme disease [LD], Rocky Mountain
spotted fever [RMSF]) as they relate to socio-demographic, geographic, and
habitat characteristics. Areas higher in disease prevalence were not necessarily
the same areas having high predicted risk of disease infection.

Of 615 ZIP

codes modeled, LD occurred in 49.9% and RMSF in 46.8%. GBT best explained
LD occurrence (misclassification rate: 0.232; average squared error: 0.187; ROC:
0.789). RMSF incidence was

best

explained with a NNET algorithm

(misclassification rate: 0.288; average square error: 0.232; ROC: 0.696).
Covariates most useful in explaining LD and RMSF were similar and included co-
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occurrences of RMSF and LD, respectively, amount of forested and non-forested
wetlands, pasture/grasslands, and urbanized/developed lands, population counts,
and median income levels of the underlying census population.
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INTRODUCTION
Because zoonotic diseases are transmitted via an arthropod vector, it is
often of interest to understand vector habitat in the epidemiologic study of
diseases. It is common in spatial epidemiology to describe vector habitat and
then create causal inference risk maps of potentially high-risk areas based on
habitat preferences (Wimberly et al. 2008; Winters et al. 2008). These geospatial
mapping exercises outline areas having high probabilities of vector prevalence,
and then infer disease risk based on probable presence or absence.

For

example, abundance of the tick genus Ixodes, one of which is the vector primarily
responsible for the transmission of Lyme disease (LD), is associated with
temperature, landscape slope (Lane and Stubbs 1990), forested areas with
sandy soils (Kitron et al. 1992), and increasing residential development (Aronoff
1989).

Tularemia incidence is positively associated with dry forested habitat

areas (Eisen et al. 2008). Populations of people living within forested areas and
on specific soils are at higher risk of contracting LD (Glass et al. 1995; Killilea et
al. 2008). Human monocytic ehrlichiosis (HME or Ehrlichia chaffeensis) is more
associated with wooded habitats compared to neighboring grassy areas (Gaff
and Schaefer 2010).
A major limitation in the study of such diseases however is the ability to
comprehensively track disease incidence at a meaningful geographic scale
(Killilea et al. 2008). Data aggregations and disease incidence rates are most
often presented at the county level (Wimberly et al. 2008; Eisen and Eisen 2007;
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Sugumaran et al. 2009). Unfortunately, county level assessments compared to
ZIP code level analyses may mask smaller isolated high risk areas as well as
obscure within county variability (Mostashari et al. 2003; Eisen et al. 2006). In
2007, the Centers for Disease Control and Prevention (CDC) called for a means
to improve data collection methods to determine probable pathogen exposure
sites based specifically on patient activity spatial patterns (Eisen and Eisen 2007).
This suggests geocoding the residential location (street address or ZIP code) of
the infected patient and conducting a radial search around that point to examine
the underlying landscape (Wieczorek et al. 2006). However, data describing
possible pathogen exposure sites are limited (Glass et al. 1995; Eisen and Eisen
2007), and means to collect this information can be very costly.

Therefore,

studies within the wildlife and ecological sciences are often limited in predictive
power due to the inability to generate large sample sizes, either because of costs,
data availability, or both (Bissonette 1999).
Administrative medical claims data contain, among other things, a
patient’s ZIP code at the time of service, date of medical service, and medical
diagnoses describing the reason(s) why the patient is seeking medical care. The
use of administrative claims data in the study of zoonotic diseases was
previously discussed (Chapters 2-3).

Use of this data is relatively easy and

inexpensive to work with, and could represent a volume rich source of persons
diagnosed with zoonotic diseases.

The geographic element of a patient’s

residence location combined with the diagnosis provides spatially explicit
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information regarding what the patient was exposed to, and potentially where the
exposure may have occurred. Spatially explicit disease case models created
using data from managed care organizations (MCO) do not exist.

It is the

purpose of this study to determine if meaningful exploratory spatial models can
be constructed at the ZIP code level to help describe the occurrence of 2 tickborne zoonotic diseases known to occur in Tennessee (LD and Rocky Mountain
spotted fever [RMSF]). The general research hypothesis is certain landscape
and socio-demographic factors are useful in explaining zoonotic disease
presence.

METHODS
Study Area
The study area for this project was described in Chapter 2, but briefly,
Tennessee is considered a southeastern state and is approximately bounded
within the southernmost west coordinate (-90.309200, 34.995800) to the northern
most east coordinate (-81.646900, 36.611900).

Estimated land cover

percentages for the state are as follows: open water (2.7%), forested wetland
(3.0%), non-forested wetland (0.4%), grassland/pasture (37.2%), cropland (5.8%),
upland deciduous forest (40.6%), upland mixed forest (4.4%), upland coniferous
forest (3.6%), urban/developed (1.9%), and non-vegetated (0.2%) (Tennessee
Wildlife Resources Agency 1997).
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Disease Case Data
Medically diagnosed cases of LD and RMSF from January 1, 2000December 31, 2009 were collected from the electronic data warehouse system of
a large MCO located in Tennessee. These diseases were selected because they
occurred in at least 20% of the sample units (i.e., ZIP codes), and therefore
would not be potentially plagued by issues related to rare event modeling. The
process of data collection was described in detail in Chapter 2, but briefly,
zoonotic disease cases within the study area of Tennessee were extracted from
MCO claims data warehouse if they had any of following diagnosis codes for LD
(ICD-9 code: 088.81) and RMSF (ICD-9 Diagnosis Code: 082.0). Disease cases
without at least 3 separate line items in the claims system were removed. Any
patient receiving medical services for one of the selected diseases prior to the
start of the study period or after the study period was removed from the analysis.

Spatial Sample Unit
This study uses two types of spatial data: 1) disease occurrence data at
the ZIP code level extracted from medical claims and 2) underlying spatial data
to describe the socio-demographic, geographic, and habitat characteristics
surrounding the ZIP code centroid. ZIP codes can have either a geographic
centroid or population-weighted centroid. A geographic centroid is defined by the
US Census Bureau as the center of the tabulation area as it relates to the
geographic extremes of the physical boundaries of the polygon. A population-
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weighted centroid is the center of the tabulation area as determined by where the
majority of the population is located within the polygon.

For this study, the

geographic centroid was converted to a population weighted ZIP code centroid to
create the spatial sample units.

This weighted-average transformation was

accomplished using the underlying inscribed census block population counts
within the enclosing ZIP code to calculate an adjusted longitude (x z ) and latitude
(y z ), following this formula:
z

xz =

z

∑ pixi
i =1
z

∑ pi
i =1

∑ py
i

,

yz =

i

i =1
z

∑ pi

Equation 3: Population-weighted centroid conversion

i =1

where
x z = transformed population-weighted x-coordinate for ZIP code z
p i = the population of the ith census block within ZIP code z
x i = the x-coordinate value of the ith census block.
Repeat for the y-coordinate.

Dependent (Response)Variable
For the purposes of this study, spatial models are considered to be
exploratory models at the ZIP code level, and separate models were built for
each of the 2 studied diseases.

Two separate modeling exercises were

conducted across the 2 diseases using different dichotomous (i.e., binary)
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response variables. The first approach assigned a value of 1 to all ZIP codes if
the disease in question was present at any time during the study period,
otherwise the ZIP is assigned a value of 0. ZIP codes with a value of 1 are
hereafter considered ‘case’ sites.
The second modeling approach assigned a 1 to only those ZIP codes with
a z-score greater than zero. This was done to explain characteristics of ZIP
codes having an observed disease case volume above expectation relative to all
other ZIP codes. The observed number of cases in a ZIP code was the per 100k
rate averaged over the study period, and the expected number of cases within a
ZIP code was derived from the statewide incidence rate averaged over the entire
study period. Thus ZIP code rates were proportional to the member population
within that ZIP code. A z-score was calculated for each ZIP code using the
standard formula:

zi =

yi − y j

σj

Equation 4: Standard z-score calculation

where
zi = z-score for ZIP code i
yi = observed per 100k rate of cases in ZIP code i averaged over the

entire study period

y j = mean of the disease rate cases averaged across the set of j ZIP
codes
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σ j = standard deviation of the disease rate cases across the set of j ZIP
codes

Independent Variables
Underlying socio-demographic, geographic, and habitat characteristics of
the landscape surrounding the population-weighted ZIP code centroid served as
explanatory variables. Clinical variables representing the per100k rate of other
zoonotic diseases (LD, RMSF, human monocytic ehrlichiosis, babesiosis,
tularemia, La Crosse viral encephalitis, and West Nile virus) within the ZIP code
were also included. Independent variables in the model are considered multilevel because data aggregations were done at 2 spatial scales, 1.6 km and 8 km.
Socio-demographic factors included total population count and median income
from the 2000 US Census Bureau estimates within 1.6 km and 8 km of the ZIP
centroid. Geographic factors included continuous distance (km) to the nearest
river/stream and the number of river kilometers within the 2 radial aggregation
bands. Habitat characteristics included the amount (km2) of land use type and
wetland type (described below) within the 2 radial aggregation bands.
Land use data was downloaded from the Tennessee Spatial Data Server
(TSDS) and is a generalized version of the detailed vegetation map that was
prepared in compliance with the National Gap Analysis Program effort. The 10
land cover types were derived from classification techniques performed on
Landsat Thematic Mapper imagery and included open water, forested wetland,
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non-forested wetland, pasture/grassland, cropland, upland deciduous forest,
upland mixed forest, upland coniferous forest, urban/developed, and nonvegetated (barren land & strip mines/rock quarries/gravel pits).

The strip

mines/rock quarries/gravel pits class were taken from ancillary data sets and
added to the classification file. The forest classes were extracted from satellite
imagery and reclassified.

Forest communities were interpreted from aerial

videography acquired in April 1995 and correlated to the satellite imagery
(Tennessee Wildlife Resources Agency 1997).
Digital wetland areal data was downloaded from the TSDS and is sourced
from the National Wetlands Inventory (NWI) data base. The US Fish and Wildlife
Service (USFWS) and the US Geological Survey (USGS) are the Federal
agencies primarily responsible for providing geospatial information relative to the
Nation's wetlands. This data layer represents the extent, approximate location
and type of wetlands and deepwater habitats in the conterminous United States.
These data delineate the areal extent of wetlands and surface waters as defined
by Cowardin et al. (1979). Certain wetland habitats are excluded from the
National mapping program because of the limitations of aerial imagery as the
primary data source used to detect wetlands. This data layer was digitized from
USGS topographic base maps.

Alpha-numeric codes describing the type of

wetland are attributed to each digitized polygon and correspond to the wetland
and deepwater classifications. For example, “L1UB1Hx” indicates the delineated
area as:
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•

L: Lacustrine (System)

•

1: Limnetic (Subsystem)

•

UB: Unconsolidated Bottom (Class)

•

1: Cobble-Gravel (Subclass)

•

H: Permanently Flooded (Water Regime modifier)

•

X: Excavated (Modifier)

There were a total of 567 different described wetland types in the
Tennessee NWI wetlands data layer.

To reduce the amount of potential

explanatory variables, the top 11 wetland types by area were selected (Table
4-1). This reduced set of wetland areas account for approximately 90% of the
entire landscape, so little information was lost and provided a refined basis for
predictive modeling.
All continuous independent variables (i.e., covariates) were transformed
using a quantitative binning procedure.

This was done to improve model

performance so as to not restrict the relationships between covariates and
response to only linear interpretations. For each covariate, 4 bins were created
using quantiles to generate groups by splitting the data into bins having
approximately the same frequency of observations. For example, the covariate
“median income” could be separated into 4 bins, where INCOME_BIN_1 has all
observations with an income less than $29,000, INCOME_BIN_2 ($29-$33,000),
INCOME_BIN_3 ($33-$39,000) and INCOME_BIN_4 (>$39.000).

These

transformed variables are then treated as ordinal dummy variables in the
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modeling procedures.

When modeling a particular disease, geographic co-

occurrence of all other diseases was included as a binary indicator (0,1 where 1
indicates another disease was also recorded in the ZIP code).
Patient level characteristics (e.g., age, gender, comorbidities) were
excluded from analyses because the intent of this study was to determine what
geographically based risk factors could explain disease occurrence. Additionally,
we aimed to produce risk factors that could be replicated in other environments
without requiring known case/patient level information.

Analytical Modeling Techniques
Four separate modeling techniques were compared (stepwise logistic
regression, classification decision tree, gradient boosted tree, neural network) to
determine which model type performs best (i.e., champion model). The modeling
dataset consisted of 615 ZIP code records with 2 different binary response
variables (evidence of disease, above average incidence according to z-score)
and all aforementioned explanatory variables. The dataset was partitioned into
two mutually exclusive data sets, a training data set, and a validation data set.
The training data set was used for preliminary model fitting, and then once the
model was built, the validation data set was used to fine-tune (to help prevent
over-fitting) and assess the final adequacy of the model. The data partitions
were created using stratified sampling (stratified by the binary response variable),
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and the training data set included approximately 80% (n=490) of the observations,
and the validation set contained the remaining 20% (n=125).
Stepwise logistic regression (SLR) is a variable selection algorithm that
begins with no candidate variables in the model, and then systematically adds
effects that are significantly associated with the response variable (Efroymson
1960). Effects can be subsequently removed if it is not significantly associated
with the response once another variable enters the model.

This selection

process continues until either 1) no other effect in the model meets the ‘stay
significance level’ or 2) the user defined number of iterations criterion is met.
The entry significance level value was set to 0.5 to ensure effects with potential
were considered, while stay significance was set to a more conservative 0.05 to
guard against Type I errors (concluding that a factor was influential when in fact it
was not).
A classification and regression (CART) decision tree (Breiman et al. 1984)
is a commonly used algorithm in data mining and machine learning techniques.
Classifications are used with nominal targets, while regression trees are used
with continuous targets.

A tree is created by applying a series of simple

interpretable rules to the data in a recursive partitioning factor using a splitting
criterion. These rules are then used to classify new observations into a series of
tree nodes. One of the major benefits of a decision tree is its ability to use
missing data which can often be as informative as known data, unlike regression
techniques which cannot process this information directly. A classification tree
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was created using the Pearson Chi-square p-value statistic as a splitting criterion.
Maximum threshold p-values for variable consideration in the splitting criterion
were set to 0.2 with a Bonferroni adjustment (to account for multiple
comparisons), and the minimum number of acceptable observations for a
categorical value was set at 15.
Gradient boosting within classification and regression trees (GBT) is an
emerging technique in data mining algorithms that has been shown to outperform
traditional decision tree approaches (De Ville 2006; Elith et al. 2008). Boosting is
an adaptive method designed to improve predictive performance by combining
multiple simple models into one overall “ensemble” model (Friedman 2001;
Friedman 2002). Boosting is described in detail elsewhere (Friedman 2001), but
briefly, this approach recursively resamples the data to generate results that form
a weighted average of the resampled data set.

The successive samples are

adjusted to accommodate previously computed inaccuracies.

This continues

until a user-defined limit is reached, then each tree within the series is combined
to form a single final algorithm explaining the response variable.
A neural network (NNET) is a type of model that is designed to mimic the
neurophysiology of the human brain, in that it attempts to “learn” as it moves
along the data and examines it.

These types of models are referred to as

feedforward backpropagation networks (Lapedes and Farber 1987). As with the
gradient boosting technique, they are typically used when understanding the
effects of the model are less important compared to model performance. That is,

114

the output of the model cannot be readily interpreted as the aforementioned SLR
and CART techniques can. In a neural network, there are three kinds of units in
the modeling procedure:
1. Input units obtain the values of covariates and standardize those values;
2. Hidden units perform internal computations, providing the nonlinearity that
makes neural networks powerful; and
3. Output units compute predicted values and compare those predicted
values with the values of the response variable
Each unit produces a single computed value and this computed value is passed
along the connections to other hidden or output units. Output units (i.e., predicted
values) are compared with the response variable value to compute the error
function in an attempt to minimize the error.

For this project, the multilayer

perceptron (MLP) method which is the most common network technique was
utilized.

The MLP was leveraged because they are best used when prior

knowledge of the relationship between inputs and targets is unknown.

Model Comparisons
All models were built using SAS® Enterprise Miner™ (SAS® 2009). A
model champion was chosen using the overall misclassification rate applied to
the validation dataset, which represents the percentage of all incorrectly
predicted observations.

In addition, the following model fit statistics were

examined: receiver operator characteristic (ROC) curves, averaged squared
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error, sensitivity, specificity, and positive predictive values (PPV). ROC curves
plot sensitivity (true positive) on the y-axis and 1-specificity (false positive) on the
x-axis, which can be used to visually interpret how well models perform relative
to one another. Models with a steep initial rise then level off are comparatively
better than models with curves that follow the 45 degree diagonal. To provide
interpretation for GBT and NNET models, the original complete data set (n=615)
was scored with the predictive algorithms produced by the final GBT and NNET
models. This scoring calculated a predictive probability ranging from 0-1 for each
observation (i.e., ZIP code), detailing the likelihood that the disease in question
would be present in the ZIP code. We then applied an explanatory CART model
to the data to determine which independent variables were most associated with
predicted probabilities greater than 0.5 (Wall and Cunningham 2000).

RESULTS
Of the 615 ZIP codes modeled, LD occurred in 49.9% (n=307), RMSF
occurred in 46.8% (n=288), and LD or RMSF occurred in 97% (n=595) of the ZIP
codes. Approximately 33% (n=204) of the ZIP codes had at least one case of LD
and one case of RMSF. Of the 307 ZIP codes with LD, 51 had above average
incidence rates of LD (i.e., z-score >0). Of the 288 ZIP codes with RMSF, 48 had
above average incidence rates (i.e., z-score >0). Lastly, 2% (n=12) of all ZIP
codes had above average incidence rates for both RMSF and LD.
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The average LD rate across all ZIP codes and the entire study period was
4.56 per 100k (SD: 9.46). The highest average LD rate (81.3 per 100k; n = 2)
occurred in ZIP code 38564 within the Knoxville region of Jackson County. The
highest raw count of LD cases (n = 29) occurred in ZIP code 37830 of Anderson
County (Knoxville region). The average RMSF rate across all counties and the
entire study period was 4.05 per 100k (SD: 9.32). The highest average RMSF
rate (98.1 per 100k; n = 1) occurred in ZIP code 37140 within the Nashville
region of Hickman County. The highest raw count of RMSF cases (n = 28)
occurred in ZIP code 38401 of Maury County (Nashville region). Approximately
38% of the LD cases occurred in the Nashville regional area (middle of state),
and only 5% occurred in the Johnson City area (northeast potion of state).
Similarly, 45% of the RMSF cases occurred in the Nashville regional area and
only 3% occurred in the Johnson City area (Table 4-2; Figure 4-1; Figure 4-2).
Exploratory models examining ZIP codes having at least one occurrence
of LD or RMSF successfully converged across all 4 modeling procedures. For
the LD models, the GBT outperformed all others with a misclassification rate of
0.232, average squared error of 0.187 and ROC value of 0.789 (Table 4-3;
Figure 4-3) using misclassification rate as the champion model selection criterion.
Covariates most useful in explaining LD occurrence within the GBT model were
co-occurrences of RMSF, amount of forested and non-forested wetlands, upland
deciduous forests and urbanized/developed lands, population counts, median
income,

and

wetland

type

PUBHh

117

(Palustrine

Unconsolidated

Bottom

Permanently Flooded Dike/Impounded).

Occurrence of RMSF was best

explained using a neural network algorithm (misclassification rate=0.288;
average square error=0.232; ROC=0.696) (Table 4-3; Figure 4-4). Similar to the
LD model, covariates most useful in explaining RMSF occurrence within the
NNET model were co-occurrences of LD, amount of forested and non-forested
wetlands, pasture/grasslands, and urbanized/developed lands, and population
counts.
The algorithms from the champion models were used to score the
validation data set (n=125).

Areas higher in disease prevalence were not

necessarily the same areas having high predicted risk of disease infection
(Figure 4-5; Figure 4-6). Table 4-3 provides a comprehensive assessment of all
modeling outcomes for LD and RMSF and details covariates useful in explaining
the variability in disease occurrence. A ZIP code was predicted to be a “case”
site if the posterior probability was greater than or equal to 0.50, and therefore all
model fit statistics are based on this predicted probability threshold. The symbols
denote the general direction of the data, where a “+” indicates a positive
relationship between the covariate and the response (i.e., as the covariate
increases, the likelihood of a disease case occurring also increases), a “-”
indicates a negative relationship between the covariate and the response (i.e., as
the covariate increases, the likelihood of a disease case occurring decreases),
and a “+ / -” indicates a non-linear relationship (i.e., in some ranges of the
covariate, the likelihood of a disease case occurring decreases while in other
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ranges, likelihood of disease increases).

Note that the interpretations of the

signs are only generalizations for two reasons: first, not all modeling procedures
can be directly interpreted, and second, raw data were transformed using the
binning procedure to segment each variable into groups thus allowing for nonliner interpretations.

Additionally, p-values for covariates are not reported

because only the SLR procedure produces this type of interpretable statistic.
Model fit was adequate for both LD and RMSF. Figure 4-7 displays the
performance of each model against the posterior probability predictions. The
dotted 45o line represents a perfect model fit based on the predictions from the
algorithm. For example, within the posterior probability range of 0.50 – 0.60 you
would expect from a perfect model that approximately 50-60% of the ZIP codes
actually had a disease case. Additionally, this chart can be used to determine
the optimal posterior probability that should be used as a threshold to assign a
predicted classification of “case” to the ZIP code. Moving the threshold value of
the prediction can thus alter the model fit statistics because model evaluation is
based in part on the ability to predict a “case”.
Exploratory models using the z-score to define ZIP codes with above
average incidence rates were unsuccessful across all modeling types.

The

models did not pick any successful covariates to explain the above average
incidence rates, and therefore each algorithm simply predicted all observations to
have below average incidence rates. No other results are reported for these
models.
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DISCUSSION
Results from this study suggest LD and RMSF incidence rates are
associated with varying landscape characteristics.

Disease incidence was

explained reasonably well within the spatially explicit models at the ZIP code
level using administrative medical claims data as a source for diagnosed cases.
It is believed this is the first study that has attempted to use claims data for
modeling the spatial characteristics of zoonotic diseases.

This study also

supports the need to collect and study disease incidence at the ZIP code level as
opposed to a more coarse county level.
Three out of the four models suggested that LD incidence increased with
increasing urbanization.

Two different covariates reflect urbanization in this

study: urbanization as a land use type and population counts. Both covariates
indicated a consistently positive relationship with disease risk across the 4
models. Assuming urbanization is indicative of residential habitation, others have
also suggested that residential factors were associated with increased risk of LD
(Steere et al. 1977; Maupin et al. 1991). Others found LD risk to be reduced in
highly developed areas (Glass et al. 1995).

It is likely that land use types

between studies are different and therefore produce different findings. Glass et
al. (1995) specifically described highly developed areas as multiunit residential
neighborhoods, and found these areas to be negatively associated with risk of
LD. The urbanization variable used in our study is defined in terms of land use
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type, not actual physical representations of housing structures. Further, Glass et
al. (1995) report an adjusted odd ratio upper confidence limit equal to 1 for this
urbanization variable, which denotes the possibility that no significant association
exists (i.e., in statistics, an odds ratio of 1 indicates the independent variable
does not have any statistical influence on the outcome varaible).
LD incidence was significantly associated with both forested and nonforested wetland areas. In a comprehensive review of literature related to LD risk,
Killilea et al. (2008) found that LD was consistently associated with forested
areas. A probable explanation is these land use types provide valuable habitat
for host abundance (McLean et al. 1993; Ginsberg et al. 2005; Ogden et al.
2008). A crude analysis between disease incidence and forested wetland area
suggest a positive correlation when forested wetlands account for up to 2.5% of
the surrounding sample area. However, disease incidence declines when the
amount of forested wetlands is above this amount.

Similarly, a positive

correlation exists between disease incidence and upland deciduous forests when
this land use type accounts for up to 24% of the surrounding sample area.
Above this amount and the relationship becomes negative. Glass et al. (1995)
reported persons living in forested areas had elevated risk (OR: 3.7; 95% CI: 1.2
– 11.8) of LD exposure. This non-linear relationship between disease incidence
within deciduous forests and non-forested wetlands may result from the complex
vector-host interaction. For example, an area that is 100% forested may not be
inhabited by humans and, therefore, reduces the possibility of disease
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transmission from vector to host. Consequently, an area that is 100% urbanized
may eliminate vector habitat, thus removing all chances of a vector-host
interaction. Borrelia burgdorferi, the causative agent of LD, may occur in urban
and suburban development areas as well as in isolated park/forest preserves
where deer, rodents, and birds can thrive (Magnarelli et al. 1995). Kitron et al.
(1992) reported that I. scapularis were most abundant on sandy soils with
deciduous forests.
The positive association between LD occurrence and median incomes
may be more an artifact of the data source rather than an actual correlation. The
data source is from persons with health insurance, both commercially insured
and government subsidized programs for those who cannot afford coverage (i.e.,
Medicaid). Relatively wealthier persons have more access to care and tend to
disproportionately utilize medical services compared to lower income persons
(Wilkinson and Pickett 2006; Lusardi et al. 2010).
Covariates explaining RMSF incidence were mostly similar to LD and thus
similar interpretation of results are assumed. However, one notable difference
was RMSF was significantly associated with the amount of pasture/grassland
within all 4 models. The American Dog tick (Dermacentor variabilis) is the most
commonly identified species responsible for transmitting the Rickettsia rickettsii
bacterial organism that causes RMSF in humans. D. variabilis is considered an
ixodid tick (hard-shell tick) and these are commonly found in grassland areas
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including pastures, old fields, clearings around homes, and brushy habitats (Liu
et al. 1995; Parola and Raoult 2001).
When evaluating either LD or RMSF, the co-occurrence of the each other
was significant throughout all 8 models. There are two, though possibly more,
likely explanations for this relationship.

As previously mentioned, significant

explanatory covariates were similar for each disease. Therefore, it is plausible
that suitable habitat features are overlapping for the tick vectors (Parola and
Raoult 2001). Another possible reason for this interaction is both diseases have
similar clinical presentations, thus cases may be misdiagnosed between the two
diseases (Masters et al. 2003). In highly endemic areas within the US where
awareness of RMSF is high, many patients receive an alternate diagnosis when
initially seeking medical attention. Cases not laboratory confirmed are frequently
not RMSF and laboratory confirmation using weak diagnostic criteria may lead to
false-positives (Helmick et al. 1984). Because of the possibility of misdiagnoses,
it is recommended that clinicians receive confirmatory laboratory results prior to
making a definitive clinical diagnosis.
Areas higher in disease prevalence were not necessarily the same areas
having high predicted risk of disease infection. This supports our original project
intent to illustrate the need to build spatially explicit models.

Traditional risk

maps can highlight temporally static areas where case volumes are high relative
to other spatial units. This approach benefits from its simplicity, however it lacks
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statistical validation and does not account for other influencing factors and is
influenced by population.
Limitations in study include the inability to definitively confirm a diagnosed
case of LD and/or RMSF as such.

Land use and wetlands data do not

necessarily reflect the same temporal period as the diagnosed disease case.
The champion models for LD and RMSF were the GBT and NNET, respectively.
Although they performed well, these modeling procedures do not produce directly
interpretable results. Therefore, the ability to describe the quantitative impact of
the covariates without deriving them from the SLR or CART results is limited.

CONCLUSIONS
Findings from this study suggest that administrative medical claims data is
a viable source to study and map disease risk for LD and RMSF. Spatial models
predicting disease risk are favorable to defining risk by mapping areas of high
incidence.

Spatial factors associated with medically diagnosed cases of

zoonoses agree with other literature using actual CDC reported cases. Little
work exists using more advanced non-linear modeling techniques like those used
in this study and it is recommended to explore these options as they may provide
better results than traditional regression-based approaches.

Administrative

medical claims data is relatively easy to access given the appropriate
permissions, relatively no cost once access is granted and provides the
researcher with a volume rich dataset from which to study.
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Table 4-1: Top 11 wetland types by area in Tennessee and selected for study
Wetland
Type

Area Percent of
Cumulative %
(sq km) Total Area

Description

L1UBHh

Lacustrine Limnetic Unconsolidated
Bottom Permanently Flooded
2726.4
Dike/Impounded

30.9%

30.9%

PFO1A

Palustrine Forested Broad-Leaved
Deciduous Temporary Flooded

1812.1

20.5%

72.0%

Riverine Lower Perennial
R2UBH Unconsolidated Bottom Permanently 1347.9
Flooded

15.3%

82.0%

PFO1C

Palustrine Forested Broad-Leaved
Deciduous Permanently Flooded

1061.7

12.0%

90.8%

PUBHh

Palustrine Unconsolidated Bottom
Permanently Flooded
Dike/Impounded

254.2

2.9%

84.6%

PFO6F

Palustrine Forested Deciduous
Semipermanently Flooded

205.3

2.3%

86.3%

PFO1F

Palustrine Forested Broad-Leaved
Deciduous Semipermanently
Flooded

109.6

1.2%

86.5%

PUBHx

Palustrine Unconsolidated Bottom
Permanently Flooded Excavated

96.7

1.1%

87.4%

R2UB3H

Riverine Lower Perennial
Unconsolidated Bottom Mud
Permanently Flooded

84.9

1.0%

88.3%

PEM1A

Palustrine Emergent Persistent
Temporary Flooded

79.5

0.9%

89.1%

PEM1C

Palustrine Emergent Persistent
Seasonally Flooded

68.5

0.8%

89.8%
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Table 4-2: Regional summary of disease distribution (Lyme disease and Rocky
Mountain spotted fever) for the 2000-09 study period within Tennessee according
to medically diagnosed claims data
Lyme disease
N (%)

Rocky Mountain
spotted fever N (%)

Total (%)

Nashville

343 (38%)

296 (45%)

639 (41%)

Knoxville

271 (30%)

149 (23%)

420 (27%)

Chattanooga

96 (11%)

87 (13%)

183 (12%)

Jackson

80 (9%)

80 (12%)

160 (10%)

Memphis

69 (8%)

26 (4%)

95 (6%)

Johnson City

44 (5%)

23 (3%)

67 (4%)

Totals

903

661
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1,564

Table 4-3: Model summary statistics for spatially explicit models describing the
occurrence of medically diagnosed cases of Lyme disease and Rocky Mountain
spotted fever for the 2000-09 study period within Tennessee
Lyme Disease (LD)

Rocky Mountain Spotted Fever
(RMSF)

Model Type
GBT
SLR
NNET CART
GBT
SLR
NNET CART
Model Performance
Misclassification Rate
0.232* 0.272
0.288
0.296
0.304 0.312 0.288* 0.296
Average Square Error
0.187
0.182
0.253
0.206
0.230 0.210 0.232 0.213
ROC
0.789
0.812
0.688
0.674
0.702 0.727 0.696 0.712
PPV
83.7% 75.0% 77.1% 85.7%
69.8% 68.5% 72.5% 70.4%
Sensitivity
66.1% 67.7% 59.7% 48.4%
62.7% 62.7% 62.7% 64.4%
Specificity
87.3% 77.8% 82.5% 92.1%
75.8% 74.2% 78.8% 75.8%
Input Variables**
Land cover
+/+
+/Forested Wetland
Non-Forested
+/Wetland
+
+/+/+
Pasture/Grassland
Upland Deciduous
+/+/Forest
+
+
+
+
+/Urban/Developed
Wetland Type
PUBHh
Geographic
+/Distance to River
Demographic
+
+
+
+
+
+
+
+/Population Counts
+
+
+/+
Median Income
Clinical
Lyme Dis. Co+
+
+
+
occurrence
+
+
+
+
RMSF Co-occurrence
* Best model chosen using lowest misclassification rate on validation
dataset
** Denotes aggregations were made at 1.6 and 8km where
applicable
NOTE: Variables missing from this table indicate non-significance across all models and plus and
minus signs indicate direction of relationship
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Figure 4-1: Spatial distribution of medically diagnosed Lyme disease cases (raw
count) within Tennessee ZIP codes during the 2000-09 study period: Dark black
outlines define regional areas
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Figure 4-2: Spatial distribution of medically diagnosed Rocky Mountain spotted
fever cases (raw count) within Tennessee ZIP codes during the 2000-09 study
period: Dark black outlines define regional areas
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Figure 4-3: Receiver operator characteristic (ROC) curves for spatial models
explaining occurrence of medically diagnosed cases of Lyme disease for the
2000-09 study period within Tennessee
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Figure 4-4: Receiver operator characteristic (ROC) curves for spatial models
explaining occurrence of medically diagnosed cases of Rocky Mountain spotted
fever for the 2000-09 study period within Tennessee
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Figure 4-5: Delineated risk areas for Lyme disease according to raw disease
incidence per 100k rates (top) and predicted probabilities from spatial predictive
models (bottom)
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Figure 4-6: Delineated risk areas for RMSF according to disease incidence per
100k rates (top) and predicted probabilities from spatial predictive models
(bottom)
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Figure 4-7: Performance of champion models as a function of the posterior
probability predictions on the validation datasets
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CHAPTER 5

USING A RETROSPECTIVE SPACE-TIME PERMUTATION SCAN STATISTIC
FOR DETECTING CLUSTERS OF ARTHROPOD-BORNE ZOONOTIC
DISEASES

ABSTRACT
Determining when and where disease prevention efforts should be
targeted is a major focus in the study of zoonotic diseases. Space-time scan
statistics were developed to detect statistically significant clusters of disease
incidence where the observed amount is above expectation. This provides a
means to study disease distribution over space and time, as well as the
underlying factors influencing disease presence. The objective of this study was
to determine if any significant spatial and/or temporal clusters existed for five tickborne (Lyme disease [LD], babesiosis, ehrlichiosis, Rocky Mountain spotted
fever [RMSF], tularemia) and 2 mosquito-borne diseases (West Nile virus [WNV],
La Crosse viral encephalitis) known to occur in Tennessee. A cross-sectional
sampling was performed for 10 consecutive years (2000-2009) across 615
population-weighted ZIP code centroids in Tennessee. Disease incidence data
were extracted from administrative medical claims data from a large
southeastern managed care organization.

SaTScan™ software was used to

detect significant clusters using a retrospective space-time permutation analysis.
Overall, 1,654 unique cases were distributed across the 7 studied diseases and 3
statistically significant clusters were detected. A significant LD cluster (P = 0.006,
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RR = 2.22, radius = 43.4 km) was detected in northeast Tennessee around ZIP
code 37710. A significant RMSF cluster (P = 0.018, RR = 3.26, radius = 87.4
km) was detected in west Tennessee around ZIP code 38006.
WNV cluster was located near the RMSF cluster.

A significant

Findings suggest these

significant cluster areas have underlying geographic/habitat features explaining
their existence, and ZIP code scale analyses may provide enhanced information
compared to county-level assessments.
efforts in non-endemic areas are warranted.
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Focused disease/vector prevention

INTRODUCTION
In ecological studies, sample units may represent an observation taken at
some location (space) and/or at some temporal event (time). Determining when
and where disease prevention efforts should be targeted is a major focus in the
study of zoonotic diseases (i.e., diseases that can be transferred from/through
animals to humans). Combining epidemiologic methods to identify disease risk
with geospatial analytics provide an opportunity to study disease distribution over
space and time, as well as the underlying factors influencing disease presence
(Glass et al. 1995; Sugumaran et al. 2009; Chapters 3 and 4). Additionally, it is
important to identify significant disease clusters in order to implement appropriate
public health precautions (Steere et al. 1977; Rogers and Randolph 2003;
Iyengar 2005; Sugumaran et al. 2009).
Identification of significant clusters is confounded by the statistical
property that any geographic region under study will always contain some highrate area by chance alone (Kuldorff et al. 1998). To address this issue, spacetime scan statistics were developed to detect non-randomly occurring clusters
while accounting for multiple statistical testing (Kulldorff 1997; Iyengar 2005;
Kulldorff 2010).

Scan statistics, like those incorporated into the SaTScan™

software package (Kulldorff 2010), have been widely implemented in various
fields of study including, but not limited to, forestry (Coulston and Riitters 2003),
wildlife biology (Miller et al. 2002; Porcasi et al. 2006; Spindler et al. 2009), and
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infectious diseases (Chaput et al. 2002; Mostashari et al. 2003; Brooker et al.
2004).
Of the approximate 1,415 species of infectious organisms known to be
pathogenic to humans, 868 (61%) are zoonotic.

Of all recently emerging

pathogens, 75% are zoonotic and are twice as likely to be associated with
emerging diseases compared to non–zoonotic pathogens.

This recent

emergence of zoonoses in the US has been attributed to climate change,
reforestation, increases

in reservoir

and

vector

populations, residential

preferences, and increased outdoor recreational activities (Taylor et al. 2001).
Currently in Tennessee, there are approximately 70 communicable diseases
required to be reported to the Tennessee State Health Department for tracking
purposes. However, problems exist with disease surveillance because multiple
systems are implemented through multiple agencies with little cross-coordination,
thus creating unnecessary duplication of efforts and inefficient use of resources.
Further, wildlife diseases are rarely covered in surveillance efforts and no
definition exists for what triggers a response for action (Dunn 2005).
In Tennessee, disease surveillance relies on a system where significant
underreporting of diseases is known to exist and publicly reported data from the
State Health Department is available only at the county level (Chapters 1 – 3).
Administrative medical claims data extracted from a managed care health plan
are effective in measuring zoonotic disease incidence across time and space
(Chapters 2 – 4).

Routinely collected administrative data is an inexpensive
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comprehensive source of disease information well-suited for retrospective study
and disease surveillance. However, only one known study leverages claims data
as

a

source

for

studying

spatio-temporal

zoonotic

disease

clustering

(Yiannakoulias and Svenson 2009). The objective of this study was to determine
if any significant spatial and temporal clusters existed for five tick-borne (Lyme
disease [LD], babesiosis, ehrlichiosis, Rocky Mountain spotted fever [RMSF],
tularemia) and 2 mosquito-borne diseases (West Nile virus, La Crosse viral
encephalitis) known to occur in Tennessee. If using medical claims data is a
viable approach, surveillance tracking of infectious zoonotic diseases across time
and space could improve by utilizing this resource.

METHODS
Study Area
The study area for this project was described in Chapter 2, but briefly
Tennessee is considered a southeastern state and is approximately bounded
within the southernmost west coordinate (-90.309200, 34.995800) to the northern
most east coordinate (-81.646900, 36.611900).

The spatial sampling unit

consisted of the 615 population-weighted ZIP code centroids within Tennessee
(Chapter 4).
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Disease Case Data
The collection of disease incidence data from the managed care
organization (MCO) data warehouse was described earlier. Briefly, all medical
claims having a primary or secondary arthropod-borne disease diagnosis code of
interest (see below) were extracted for the study period January 1, 2000December 31, 2009. Medical claims having one of the following diagnosis codes
were retained for study:
Tick-Borne Diseases:
•

Babesiosis (ICD-9 code: 088.82)

•

Borreliosis - Lyme disease (LD) (ICD-9 code: 088.81)

•

Ehrlichiosis - human monocytic ehrlichiosis (HME) (ICD-9 code: 082.41)

•

Rickettsiosis - Rocky Mountain spotted fever (RMSF) (ICD-9 Diagnosis
Code: 082.0)

•

Tularemia (ICD-9 code: 021)

Mosquito-Borne Diseases:
•

La Crosse viral encephalitis (LACV) (ICD-9 code: 062.5)

•

West Nile virus (WNV) (ICD-9 code: 066.4)

Any patient receiving medical services for one of the selected diseases prior to
the start of the study period or after the study period was removed from the
analysis. Disease cases were aggregated to the ZIP code on the medical claim,
which represents the ZIP code of residence for the patient at the time medical
services were rendered.

Population-weighted ZIP code centroids were
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geocoded and used in the cluster detection analysis as the spatial sample unit.
The day, month, and year of the diagnosis were also extracted from the claims
data.

Retrospective Space-Time Permutation Analysis
Previous work has shown LD and RMSF incidence rates

vary

geographically (Chapters 2 – 4). Traditional risk maps can highlight temporally
static areas where case volumes are high relative to other spatial units (e.g.,
Figure 5-1). Spatial kriging, a geospatial interpolation process, can smooth out
these risk maps so that risk is not clearly defined by ZIP code boundaries (e.g.,
Figure 5-2). These approaches benefit from their simplicity, however, they lack
the statistical rigor (Chapter 4) and capability to simultaneously vary across time
and space.

To overcome this issue, a retrospective space-time permutation

analysis was conducted for each selected disease to determine if any significant
space-time clusters exist within Tennessee and throughout the study period.
This methodology is described in detail in Kulldorff et al. (2005). Briefly, a scan
statistic is created by moving a cylindrical window over each ZIP code centroid,
where the circular base represents the size of the search radius space around
the centroid and the cylinder height represents a pre-defined time duration.
Significant cluster detection is determined using this scan statistic by creating a
relatively infinite number of overlapping cylinders to define the scanning window,
each being a possible candidate for a disease cluster. Within each cylinder, the
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actual and expected number of disease cases, along with a Poisson generalized
likelihood ratio (GLR) is calculated. Under the Poisson assumption, the GLR for
any given scan window is calculated as:

 c 


 E[c] 

c

 T −c 


 T − E[ c ] 

T −a
I

where T is the total number of cases, c is the actual number of cases within the
scan window, E[c] is the expected number of cases within the window under the
null hypothesis, and I is the indicator function which is equal to 1 if c > E [c] or 0
otherwise (Kulldorff 1997). To detect clusters with high rates, I was set to 1 (i.e.,
observed value should be higher than the expected value). Using Monte Carlo
simulation (Dwass 1957), the actual GLR is compared to simulated GLRs within
the cylinder.

Relative risk (RR) for a significant cluster is calculated as the

observed number of cases divided by the expected number of cases. Statistical
significance is defined in terms of a p-value, and is computed as p=R/(S+1),
where R is the rank of the GLR for the actual observation and S is the number of
simulated cases. For example, if you simulate 999 cases, you thus obtain 999
GLR values. You then rank order these 999 GLRs from highest to lowest, where
the highest GLR indicates the highest probability a cluster exists at that site. You
then insert the actual GLR into this rank ordered list, and if the actual GLR is
higher than the 50th highest simulated GLR, then the cluster is statistically
significant at an alpha of 0.05 (i.e., 50 / 999+1). This analysis adjusts for any
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potential purely spatial and/or temporal variation, does not require a control
comparison, and is most appropriate when information about the population-atrisk is unavailable or irrelevant (Kulldorff et al. 2005).

SaTScan™ software

v9.0.1 (Kulldorff 2010) was used for all cluster detection analysis.

Specific

software settings for these analyses included a retrospective space-time
permutation probability model scanning for areas of high disease incidence, time
aggregation of 1 month, a maximum spatial cluster size equal to 25% of the atrisk population, maximum temporal cluster size equal to 25% of the study period
and a maximum of 999 Monte Carlo replications. Maps of significant clusters
were generated using Maptitude™ v5.0 GIS software (Caliper Corporation 2008).

RESULTS
Overall disease case results are presented earlier in Chapter 2, but briefly,
1,654 unique cases were distributed across the 7 studied diseases and used in
the cluster detection analyses. The majority of disease cases were LD (n = 903;
55%), followed by RMSF (n = 661; 40%). The remaining 5 diseases made up the
residual 5% of disease cases. Davidson County accounted for 9.7% (n=88) of all
LD cases and 21.4% (n = 3) of HME cases. Maury County had the highest
number of RMSF cases (n = 47; 7.1%) while Shelby County had the highest
number of WNV (n = 8; 38.1%) cases.
A significant LD cluster (53 cases, P = 0.006, RR = 2.22) was detected
centering in the northeastern area of Tennessee (36.164667 N, 84.236972 W;
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radius = 43.4 km) around ZIP code 37710 (Anderson County), approximately 35
km northwest of Knoxville (
Figure 5-3). This cluster encapsulated 51 ZIP code areas and was specifically
associated with the time period beginning October 2001 and ending August 2003.
A secondary cluster of cases, though non-significant (18 cases, P = 0.189, RR =
3.69), was centered around ZIP code 38483 of Lawrence County (35.430774 N,
87.323665 W; radius = 66.7 km), approximately 95 km southwest of Nashville.
This cluster was specifically associated with the time period beginning August
2003 and ending May 2004.

There were 25 other non-significant clusters

detected throughout the state with p-values greater than 0.5 (50% of Monte Carlo
replications).

To reduce the amount of information, we only present the

significant cluster information (Table 5-1) but graphically show all secondary
clusters in the map figures for spatial reference (
Figure 5-3 - Figure 5-5).
A significant cluster of RMSF (24 cases, P = 0.018, RR = 3.26) was
detected centering in the western side of Tennessee (35.707710 N, 89.084874
W; radius = 87.4 km) around ZIP code 38006 (Crockett County), approximately
105 km northeast of Memphis (Figure 5-4). This geographically large cluster
encapsulated 108 ZIP code areas and was specifically associated with the time
period beginning April 2009 and ending October 2009. A secondary cluster of
cases, though non-significant at alpha = 0.05 (4 cases, P = 0.10, RR = 36.72),
was centered around ZIP code 37082 of Cheatham County (36.088518 N,
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87.122007 W; radius = 9.6 km), approximately 31 km west of Nashville. This
cluster was specifically associated with the time period beginning May 2006 and
ending June 2006.

There were 23 other non-significant clusters detected

throughout the state with p-values greater than 0.5 (50% of Monte Carlo
replications) (Table 5-1; Figure 5-4).
A significant cluster of WNV (4 cases, P = 0.044, RR = 5.25) was detected
centering in the western side of Tennessee (35.752529 N, 89.538019 W; radius
= 64.5 km) around ZIP code 38063 (Lauderdale County), approximately 83 km
northeast of Memphis (Figure 5-5). This cluster encapsulated 40 ZIP code areas
and was specifically associated with the time period beginning July 2006 and
ending September 2006 (Table 5-1).
The most likely cluster of HME was not statistically significant (2 cases, P
= 0.57, RR = 7.00), and was centered around ZIP code 37174 of Maury County
(35.728158 N, 86.910828 W; radius = 17.8 km) approximately 50 km south of
Nashville. The most likely cluster of tularemia was not statistically significant (3
cases, P = 0.37, RR = 10.5), and was centered around ZIP code 38341 of
Benton County (35.874121 N, 88.087316 W; radius = 34.5 km) approximately
190 km northeast of Memphis and 120 km southwest of Nashville. The most
likely cluster of LACV was not statistically significant (2 cases, P = 0.930, RR =
5.00), and was centered around ZIP code 37705 of Anderson County (36.216522
N, 84.014630 W; radius = 14.1 km) approximately 20 km east of the significant
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LD cluster center.

Overall, 3 cases of babesiosis, were found, however no

clusters were detected (Table 5-1).

DISCUSSION
Arthropod-borne zoonotic diseases are known to vary geographically and
occur in significant clusters (e.g., Eisen et al. 2008; Adjemian et al. 2009). Often,
spatio-temporal modeling of these diseases is conducted at the county level or
higher spatial scale (e.g., Mostashari et al. 2003; Wimberly et al. 2008; Adjemian
et al. 2009). While this scale may be appropriate for multi-state initiatives, it can
mask smaller isolated high risk areas as well as obscure within county variability
(Mostashari et al. 2003; Eisen et al. 2006). Analyses at a finer spatial scale like
ZIP codes could improve disease surveillance activities while simultaneously
protecting the identity of infected patients. Further, significant underreporting of
zoonotic diseases by diagnosing clinicians exists (Marier 1977; Meek et al. 1996;
Young 1998; Koo and Caldwell 1999; Figueiras et al. 2004) and could be
improved using administrative medical claims data (Chapters 2 and 3). Thus the
importance of the current study was our ability to successfully demonstrate
spatio-temporal modeling at the ZIP code scale using medical claims data from a
health plan.
LD is the most frequently reported vector-borne disease in the US. In
2009 there were 29,780 cases reported nationwide, with 32 occurring in
Tennessee (CDC MMWR 2010).

LD is caused by the bacterium Borrelia

150

burgdorferi, which is transmitted to humans via the Blacklegged or deer tick
(Ixodes scapularis), the same tick responsible for transmitting babesiosis and
certain forms of ehrlichiosis. Spatial clustering of LD is common in endemic
areas in the northeastern US (Steere et al. 2004; Doll 2008 unpublished), but is
not considered endemic in Tennessee. Infected tick vectors are considered rare
(ALDF 2010) and in a sample of nearly 900 blacklegged ticks, no evidence of
Borrelia burgdorferi was found within the state of Tennessee (Rosen 2009).
Previous work disputes these findings, suggesting LD incidence may be 7 times
higher (3.7 vs. 0.49 per 100k) than state reported values (Chapter 2). Further,
the current study suggests LD varies geographically within Tennessee and
indicates the presence of a significant cluster in the northeast part of the state.
There is reasonable evidence to suggest the infection occurred within/near the
patient’s residence (Maupin et al. 1991; Glass et al. 1995; Cromley et al. 1998;
Eisen et al. 2006) and not while traveling to an endemic area. With LD on the
rise nationwide (CDC NCEZID 2010), there is a need for more active surveillance
in non-endemic states and improved reporting to address underreporting.
The significant LD cluster northwest of Knoxville, TN encompassed 51 ZIP
codes. The Knoxville cluster center was located approximately 80km from the
county-level based significant LD cluster from previous work (LM1 in Chapter 3),
and was nearly one-half its size. The comparatively smaller size was expected,
given that the data is at a smaller spatial scale and one would expect better
granularity. However, the spatial displacement of cluster centers (80 km) was
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unexpected. Additionally, the time periods of the clusters were similar, but the
Knoxville ZIP cluster started 2 months before and ended 7 months before the
county-level cluster. This suggests that ZIP code data could not only provide
enhanced spatial scale, but may produce fundamentally different results
compared to larger spatial scales. We performed a post-hoc analysis to compare
the ZIP codes within the Knoxville cluster to all other Tennessee ZIP codes
outside the cluster. Findings from this analysis support earlier work (Chapter 4)
that LD is more prevalent in urbanized areas of greater populations, as well as
forested areas.

Compared to non-cluster areas, ZIP codes in the Knoxville

cluster had over 5 times the median amount of urbanized area within an 8 km
band surrounding the centroid and median population counts were nearly 3 times
higher.

The median amount of upland coniferous forested area was

approximately 2.5 times greater within the cluster compared to outside the cluster.
Findings go on to suggest the occurrence of LACV and tularemia was 4.7 and
2.2 times higher, respectively, in the Knoxville cluster compared to non-cluster
ZIP codes.
RMSF is the most severe tick-borne rickettsial illness in the US and is
caused by the Rickettsia rickettsii bacterial organism (CDC NCEZID 2010).
Infections occur most commonly in the southeastern and south central US and
are typically transmitted from the bite of an infected American Dog tick
(Dermacentor variabilis). Symptoms include the development of a rash within 2
to 4 days after the onset of fever, and can be non-descript or mimic other
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illnesses with headache, muscle pain, nausea, and lack of appetite. In 2009
there were 1,393 cases reported nationwide, with 184 (13%) occurring in
Tennessee (CDC MMWR 2010) making it the 3rd highest case count in the US.
In a study of RMSF disease severity, Tennessee ranked 2nd only to North
Carolina in the percentage of fatal RMSF cases (Adjemian et al. 2009).
The significant RMSF cluster detected in western Tennessee (Crockett
County) was spatially large (87.4 km radius) encompassing 108 ZIP codes but
temporally small (7 months).

The Crockett cluster was nearly identical to a

previously detected significant RMSF cluster using county-level data (Cluster
RM1 in Chapter 3).

The ZIP and county-level clusters had centers located

approximately 20 km apart, both were approximately equal in size and covered
the same time period. The Crockett cluster center was located only 90 Euclidean
kilometers from the cluster center of six fatal RMSF cases reported by Adjemian
et al. (2009), and was completely inscribed within its 250 km radius.

The

Adjemian et al. cluster represented 26% of all fatal RMSF cases reported during
their 5 year study. The eastern most edge of the Crockett cluster was only 1.5
km away from overlapping the Adjemian et al. cluster center.
Closer examination of the 108 inscribed ZIP codes support earlier findings
that RMSF incidence is associated with the presence of forested wetlands
(Chapter 4). ZIP codes within the Crockett cluster had over 50 times the median
amount of surrounding forested wetland habitat, 5 times the amount of cropland
(unfounded in earlier results), number of WNV cases were 1.8 times higher and
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tularemia cases 4.5 times higher than the remaining areas of the state. Contrary
to earlier findings, the cluster area was less populated with lower LD rates
compared to non-cluster ZIP codes. The southwest edge of the Crockett cluster
narrowly misses including the Memphis population and comprises the more rural
parts of Tennessee. This supports others that very complex interactions are at
work and no single attribute can drive high incidence rates (Holman et al. 2001;
Goddard 2008; Adjemian et al. 2009). Because our data were aggregated to the
ZIP code scale rather than the county, this may better delineate the focus area
Adjemian and colleagues suggest is needed for studying RMSF infections.
The West Nile virus (WNV) was first detected in the US in 1999 and
became notifiable in 2002. WNV is spread to humans through the bite of an
infected mosquito, typically thought to be the Culex pipiens mosquito, which
become infected after feeding on infected birds. Though the virus quickly spread
across the US from 1999 through 2001, neuroinvasive disease incidence
remained low until 2002 when large outbreaks in the Midwest and Great Plains
occurred.

Approximately 80 percent of people infected with WNV are

asymptomatic. Less than 1% of people infected will have severe life-threatening
symptoms, such as high fever, neck stiffness, stupor, disorientation, coma,
tremors, convulsions, muscle weakness, vision loss, numbness, and paralysis
(CDC NCEZID 2010).

There were 329 reported cases of non-neuroinvasive

West Nile virus in 2009, 4 of which occurred in Tennessee. Additionally, there

154

were 361 reported cases of neuroinvasive West Nile virus in 2009, 4 of which
occurred in Tennessee (CDC MMWR 2010).
Similar in geographic locale to RMSF, a significant WNV cluster was also
detected in west Tennessee (Lauderdale County) and was over 85% inscribed
within the RMSF Crockett cluster. This was an interesting find because a nearly
identical (spatial and temporal) WNV cluster was detected using county-level
MCO data, but it was not statistically significant (P = 0.702) (Chapter 3, not
reported).

ZIP codes within the WNV cluster had similar attributes to the

Knoxville LD and Crockett RMSF clusters. The median amount of croplands and
forested and non-forested wetlands within the WNV cluster were 10 to 20 times
higher inside the cluster compared to ZIP codes outside of the cluster.
Additionally, urbanization was higher within the cluster. Several wetland types
were more prevalent inside the cluster compared to outside, including emergent
and semi-permanently flooded deciduous forested wetlands.

It is well

established that mosquitoes thrive in wetland habitat areas and degraded
wetlands can provide ideal habitat for WNV carrying mosquitoes.

Mosquito

larvae feed on algal blooms created by microbial growth in nutrient rich
contaminated waters. Filling or draining wetlands may not provide the necessary
habitat for mosquito predators and thereby increases mosquito outbreaks.
Restoring damaged or degraded wetlands could help control the spread of WNV,
as healthy wetlands can sustain numerous species of mosquito-eating fish,
amphibians, insects and birds (US EPA 2004). Early warning systems designed
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to detect an uprising in WNV can be effective and efficient means to preventing
WNV (Mostashari et al. 2003; Gosselin et al. 2005).
Limitations of this study include the possibility that identified clusters are
the result of some unmeasured variable that could vary geographically, such as
climate,

demographics,

or

clinician

diagnostic

abilities/patterns.

Using

administrative claims data, we cannot definitively know if the clinician diagnosed
cases meet the CDC criteria for confirmed or probable. However, results support
earlier findings relating disease occurrence to favorable habitat conditions. The
permutation scan statistic is susceptible to changes in the underlying population
over long periods of time, and significance may be biased by this population
change rather than an actual disease incidence change. However, the significant
clusters detected in this study were not localized to the latter part of the study
period, thus it can be assumed the overall changing population was not an issue.

CONCLUSIONS
This study successfully demonstrated spatio-temporal modeling at the ZIP
code scale using medical claims data from a MCO is possible, and may provide
enhanced information compared to county-level assessments.

Significant

clusters of LD, RMSF, and WNV were detected in Tennessee during the 2000-09
study period. These significant cluster areas have underlying geographic/habitat
features that help explain their existence. Further work investigating clusters
while adjusting for potential confounding effects such as demographic and
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geographic factors is warranted.

Additionally, findings suggest that focused

disease/vector prevention efforts in non-endemic areas are warranted.
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Table 5-1: Spatio-temporal cluster analyses output statistics for statistically
significant clusters of arthropod-borne zoonotic diseases
Longitude

Radius
(km)

Time
Period
of
Cluster

P
value*

Num.
of
Cases

Relative
Risk
†
(RR)

36.1647

-84.2370

43.4

10/018/03

0.006

53

2.22

35.7077

-89.0849

87.4

4/0910/09

0.018

24

3.26

0.044

4

5.25

ZIP
Code
Center

Latitude

Lyme
disease

37710

Rocky
Mountain
spotted
fever

38006

Human
monocytic
ehrlichiosis

no significant clusters

Tularemia

no significant clusters

La Crosse
viral
encephalitis

no significant clusters

West Nile
virus

38063

35.7525

-89.5380

64.5

7/069/06

* P value derived from 999 Monte Carlo simulations
†

Relative risk (RR) calculated as the number of observed cases divided by the number of
expected cases. RR>1 indicates case rates above expectation
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Figure 5-1: Lyme disease risk map created by simple aggregation of raw counts
to ZIP codes for the 2000-09 study period within Tennessee
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Figure 5-2: Lyme disease risk map created by spatial kriging (geospatial
interpolation method) of raw counts to ZIP codes for the 2000-09 study period
within Tennessee

164

Figure 5-3: Location and radius of clusters of increased rates of medically
diagnosed Lyme disease cases identified in Tennessee for the 2000-09 study
period.
NOTE: Statistically significant clusters are shaded in grey.
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Figure 5-4: Location and radius of clusters of increased rates of medically
diagnosed Rocky Mountain spotted fever (RMSF) cases identified in Tennessee
for the 2000-09 study period.
NOTE: Statistically significant clusters are shaded in grey.
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Figure 5-5: Location and radius of clusters of increased rates of medically
diagnosed West Nile virus (WNV) cases identified in Tennessee for the 2000-09
study period.
NOTE: Statistically significant clusters are shaded in grey
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